CYP2E1

/ SCIENCE / By
  1. A case control study on relationship between lung cancer and genetic polymorphism of CYP1A1, CYP2E1 and GSTM1 in Han Nationality in Guangzhou area
  2. A case control study on the impact of CYP2E1 and GST-M1 polymorphisms on the risk of lung cancer
  3. A Case–control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk …
  4. A case-control study of CYP2E1 (PstI) and CYP1A1 (MspI) polymorphisms in colorectal cancer
  5. A Case-Control Study on Effects of Genetic Polymorphisms of GSTM1, GSTT1, CYP1A1 and CYP2E1 on Risk of Lung Cancer.
  6. A comparison of substrate dynamics in human CYP2E1 and CYP2A6
  7. A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits
  8. A decrease in S-adenosyl-L-methionine potentiates arachidonic acid cytotoxicity in primary rat hepatocytes enriched in CYP2E1
  9. A dietary ethanol protocol for CYP2E1 induction in CD-1 mice and its application to studies on the genotoxicity, immunotoxicity and metabolism of low-level benzene.
  10. A Haplotype Analysis of CYP2E1 Polymorphisms in Relation to Alcoholic Phenotypes in Mexican Americans
  11. A High Throughput Screening Assay to Screen for CYP2E1 Metabolism and Inhibition Using a Fluorogenic Vivid® P450 Substrate
  12. A Meta-analysis of CYP2E1 Genetic Polymorphism and Gastric Cancer Susceptibility [J]
  13. A meta-analysis on association of CYP2E1 rs2031920 and rs3813867 polymorphisms with breast cancer risk
  14. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping
  15. A Nanosensor System Based On Disuccinimydyl–CYP2E1 for Amperometric Detection of the Anti-Tuberculosis Drug, Pyrazinamide
  16. A negative cooperativity mechanism of human CYP2E1 inferred from molecular dynamics simulations and free energy calculations
  17. A novel lipopolysaccharide‐modulated Jun binding repressor in intron 2 of CYP2E1
  18. A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a …
  19. A novel role of CYP2E1 in human megakaryocyte development
  20. A polymorphism in the 5′-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population
  21. A reaction network model for CYP2E1-mediated metabolism of toxicant mixtures
  22. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma
  23. A relationship between genetic polymorphisms of CYP2E1 and susceptibility of acute leukemia in Gansu population
  24. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma
  25. A single nucleotide polymorphism in the CYP2E1 gene promoter affects skatole content in backfat of boars of two commercial Duroc-sired crossbred populations
  26. A study for regulation of ethanol-inducible P450(CYP2E1) on CCl4-induced hepatic damage
  27. A study on the effects of Lauric acid on ROS formation and CYP2E1 mRNA expression in alcohol-induced HEPG2 cells
  28. A Study on the Optimization of CYP2E1 Enzyme Activity in C57Bl/6 Mouse Brain and Liver/C57Bl/6 Fare Beyin ve Karaciger Mikrozomlarinda CYP2E1 Enzim …
  29. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1
  30. A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland …
  31. A temporal study on the histopathological, biochemical and molecular responses of CCl4-induced hepatotoxicity in CYP2E1-null mice
  32. A-71G> T Nucleotide Substitution uncouples IFN-[gamma]-dependent Suppression of CYP2E1 mRNA
  33. Abnormal liver function associated with polymorphism of GSTT1, GSTM1 and CYP2E1 in workers exposed to N, N-dimethylformamide
  34. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect
  35. Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1)
  36. Acetaldehyde as well as ethanol is metabolized by human CYP2E1
  37. Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes
  38. Acetaminophen alters microsomal ryanodine Ca2+ channel in HepG2 cells overexpressing CYP2E1
  39. Acetaminophen and Isoniazid treatment leads to oxidative stress and cytotoxicity in cerebellar granule neurons possibly by CYP2E1 activation
  40. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes
  41. Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice
  42. Aconitine, a famous active and toxic alkaloid, has no impact on the activities of CYP1A2, CYP2D6, CYP2E1, and CYP3A in rats
  43. Action-mechanisms of Genetic Polymorphism in the CYP2E1 on Susceptibility to Polycyclic Aromatic Hydrocarbons
  44. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1)
  45. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics
  46. Activity of immobilised rat hepatic microsomal CYP2E1 using alumina membrane as a support
  47. Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and-independent pathways
  48. Additive effects of mitochondrion-targeted cytochrome CYP2E1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes
  49. Adenovirus mediated overexpression of CYP2E1 increases sensitivity of HepG2 cells to acetaminophen induced cytotoxicity
  50. Adenovirus‐mediated expression of Cu/Zn‐or Mn‐superoxide dismutase protects against CYP2E1‐dependent toxicity
  51. Adenovirus-mediated expression of CYP2E1 produces liver toxicity in mice
  52. ADH2 and CYP2E1 genetic polymorphisms: risk factors for alcohol-related birth defects
  53. Administration of the tris salt of α-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal α-tocopherol levels and protects against carbon tetrachloride …
  54. Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective
  55. Adverse Birth Outcomes Associated with Maternal Smoking and Polymorphisms in the N-Nitrosamine-Metabolizing Enzyme Genes NQO1 and CYP2E1
  56. Age-dependent features of CYP3A, CYP2C, and CYP2E1 functioning at metabolic syndrome
  57. Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats
  58. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?
  59. ALCOHOL AND CANCER SY05-1 CARCINOGENIC ETHENO DNA ADDUCTS GENERATED DURING INFLAMMATION AND CYP2E1 INDUCTION IN VARIOUS …
  60. Alcohol intake and folate antagonism via CYP2E1 and ALDH1: Effects on oral carcinogenesis
  61. Alcohol Suppresses Cardiovascular Diurnal Variations In Male Normotensive Rats: Role Of Reduced PER2 Expression And CYP2E1 Hyperactivity In The Heart
  62. Alcoholic liver disease: from CYP2E1 to CYP2A5
  63. Alcohol-Induced Increase in the Content of CYP2E1 in Human Liver Microsomes Causes a Multifold Activation of CYP3A4 and Attenuates its Cooperativity
  64. ALDH2 and CYP2E1 genotypes, urinary acetaldehyde excretion and the health consequences in moderate alcohol consumers
  65. All trans retinoic acid modulates TNF-α and CYP2E1 pathways and enhances regression of ethanol-induced fibrosis markers in hepatocytes and HSCs in abstaining …
  66. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian …
  67. ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES
  68. Allylnitrile metabolism by CYP2E1 and other CYPs leads to distinct lethal and vestibulotoxic effects in the mouse
  69. Alteration in the expression of cytochrome P450s (CYP1A1, CYP2E1, and CYP3A11) in the liver of mouse induced by microcystin-LR
  70. Alterations in toxicokinetics of trichloroethylene (TCE) and trichloroacetic acid (TCA) due to cytochrome P450 2E1 (CYP2E1) induction
  71. Altered ethylbenzene-mediated hepatic CYP2E1 expression in growth hormone-deficient dwarf rats
  72. Amelioration of oxidative stress by dandelion extract through CYP2E1 suppression against acute liver injury induced by carbon tetrachloride in sprague‐dawley rats
  73. An estimate of polymorphism of ADH1B, ALDH2, and CYP2E1 alcohol biotransformation genes in Siberian indigenous and immigrant populations
  74. An improved in vitro method for screening toxin and medicine targeting CYP2E1
  75. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)
  76. An investigation of CYP2E1 phenotype determination utilizing modeling and simulation studies
  77. An investigation of the induction of hepatic CYP2E1 by low doses of nicotine in the rat.
  78. An Rsa I Polymorphism in the CYP2E1 Gene Does Not Affect Lung Cancer Risk in a Japanese Population
  79. An Updated Meta-Analysis On CYP2E1 RsaI/PstI And DraI Polymorphisms And Risk Of Anti-Tuberculosis Induced Hepatotoxicity: Evidence From 26 Studies
  80. Analysis of CYP2E1 and GSTM1 polymorphisms for the determination of genetic susceptibility to Korean patients with colon cancer
  81. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans
  82. Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma
  83. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling
  84. Analysis of ethanol metabolic enzymes in primary human mammary epithelial cells and MCF‐10A cells: possible participation of CYP2E1 in ethanol‐induced oxidative …
  85. Analysis of human CYP2E1 mRNA in a HepG2 cell line by reverse transcription-polymerase chain reaction (RT-PCR)
  86. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population.
  87. Analysis of protein and mRNA expressions of CYP1A1, CYP2E1, NQO1 and GST enzymes in liver, colon and prostate cancer cell lines to study drug and …
  88. and CYP2E1 and N‐terminal truncated CYP1A1 proteins in Saccharomyces cerevisiae − role of protein kinase A in the mitochondrial targeting of CYP2E1
  89. Antibiotic furazolidone induces CYP1A but not CYP2E1 subfamily in rat liver
  90. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity
  91. Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress
  92. Antioxidant Peptides from Protein Hydrolysate of Microalgae Navicula incerta and their Protective Effects in Hepg2/CYP2E1 Cells Induced by Ethanol
  93. Antioxidant Properties of Proanthocyanidins Attenuate Carbon Tetrachloride (CCl4)–Induced Steatosis and Liver Injury in Rats via CYP2E1 Regulation
  94. Apigenin protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPARα-mediated lipogenic gene …
  95. APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson’s disease in a Japanese population
  96. Application of a map Bayesian method for CYP2E1 phenotyping
  97. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice
  98. Area Under the Plasma Concentration–Time Curve of Inorganic Fluoride Following Sevoflurane Anesthesia Correlates with CYP2E1 mRNA Level in …
  99. Aspartame administration and insulin treatment altered brain levels of CYP2E1 and CYP3A2 in streptozotocin-induced diabetic rats
  100. Assessing Specificity of Indazole Derivatives as Inhibitors to CYP2E1
  101. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients …
  102. Association analysis of alcohol metabolizing enzymes ADH1B, ADH7, CYP2E1 gene polymorphism with risk for coronary atherosclerosis
  103. Association analysis of SNPs in the porcine CYP2E1 gene with skatole, indole, and androstenone levels in backfat of a crossbred pig population
  104. Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury
  105. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis
  106. Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis
  107. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
  108. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta‑analysis of 32 case‑control studies
  109. Association between CYP2E1 polymorphisms and susceptibility to prostate cancer
  110. Association between genetic polymorphism of GSTM1, CYP2E1 and susceptibility to cervical cancer and its precancerous lesions in Uighur women in Xinjiang
  111. Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility: a case control study
  112. Association between genetic variants in CYP2E1 and CTRC genes and susceptibility to alcoholic pancreatitis: A systematic review and meta-analysis
  113. Association between polymorphism of GSTP1, GSTT1, GSTM1 and CYP2E1 genes and susceptibility to benzene-induced hematotoxicity
  114. Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high …
  115. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis
  116. Association between the TP53 and CYP2E1* 5B gene polymorphisms and non-small cell lung cancer
  117. CYP2E1_gene_polymorphism.13.aspx”>Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai’an population, China
  118. CYP2E1_gene_polymorphisms_with_prostate_cancer_in_a_Lebanese_population/links/5635d13b08aebc003fff7840.pdf”>Association of CYP1A1 and CYP2E1 gene polymorphisms with prostate cancer in a Lebanese population
  119. Association of CYP2E1 and CYP1A1m2 (BsrD1) polymorphisms with cytogenetic biomarkers in petrol pump workers
  120. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease
  121. Association of CYP2E1 gene polymorphism with predisposition to cancer development
  122. Association of CYP2E1 gene polymorphisms with bladder cancer risk: A systematic review and meta-analysis
  123. Association of CYP2E1 of PON2311 polymorphisms in neonates with preterm
  124. Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide
  125. Association of CYP2E1, NQO1 and GST genetic polymorphisms with risk of acute lymphoblastic leukemia in turkish children
  126. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
  127. Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta …
  128. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: A case‐control study in Chinese population
  129. Association of GSTM1, GSTT1 and CYP2E1 gene polymorphisms with antituberculosis drug induced hepatotoxicity in North Indian population
  130. Association of GSTM1, GSTT1, GSTP1 and CYP2E1 single nucleotide polymorphisms with colorectal cancer in Iran
  131. Association of GSTM1, P1, T1 and CYP2E1 Single Nucleotide Polymorphisms with Colorectal Cancer in Iran: 391
  132. Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis
  133. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
  134. Association of radiation risk in the second and third generations with polymorphisms in the genes CYP1A1, CYP2E1, GSTP1 and changes in the thyroid
  135. Association of the blood biochemical index with CYP2E1 5’flanking region Rsa I/Pst I gene polymorphism and alcohol consumption habit in Southern Taiwan …
  136. Association of the CYP2E1, FMO3, NQO1, GST, NOS3 genetic polymorphisms with ischemic stroke risk in Turkish population
  137. Association Studies of Polymorphisms of CYP2E1 Gene in Alcoholics with Cirrhosis, Antisocial Personality, and Normal Controls
  138. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China
  139. Associations between CYP2E1 promoter polymorphisms and plasma 1, 3-dimethyluric acid/theophylline ratio
  140. Associations between CYP2E1 promoter polymorphisms and plasma 1, 3-dimethyluric acid/theophylline ratios
  141. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
  142. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis
  143. Associations of Rsa I polymorphism at the 5’flanking region of CYP2E1 and PON2 148 polymorphism in neonates with preterm delivery
  144. Author Correction: Effect of BI-1 on insulin resistance through regulation of CYP2E1
  145. Author’s Reply to Reith:“Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”
  146. Autophagy protects against CYP2E1/chronic ethanol-induced hepatotoxicity
  147. B107 TUBERCULOSIS: ISSUES DURING TREATMENT: An Updated Meta-Analysis On CYP2E1 Rsai/psti And Drai Polymorphisms And Risk Of Anti-Tuberculosis …
  148. Baicalin ameliorates liver injury induced by chronic plus binge ethanol feeding by modulating oxidative stress and inflammation via CYP2E1 and NRF2 in …
  149. Benzene-induced genotoxicity in mice in vivo detected by the alkaline comet assay: reduction by CYP2E1 inhibition
  150. bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in …
  151. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation
  152. Binge alcohol promotes acute liver injury through a CYP2E1‐HIF‐1α‐dependent apoptosis pathway in mice and humans (1010.1)
  153. Binge alcohol promotes hypoxic liver injury through a CYP2E1–HIF-1α-dependent apoptosis pathway in mice and humans
  154. Bioactivation of 1, 1-dichloroethylene by CYP2E1 and CYP2F2 in murine lung
  155. Bioactivation of 1, 1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes
  156. Bioinformatic Analysis of the Main Characteristics and Structure of the Gene Encoding CYP2E1 Protein.
  157. Bioinformatics of CYP2E1 CpG intron methylation sites and application to HAR1-RELN sequence analysis
  158. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
  159. Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription
  160. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics
  161. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry
  162. Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice
  163. by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3
  164. Ca2+-dependent and independent mitochondrial damage in HepG2 cells that overexpress CYP2E1
  165. Camelus dromedarius Putative Cytochrome P450 Enzyme CYP2E1: Complete Coding Sequence and Phylogenetic Tree
  166. Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1
  167. CARBON MONOXIDE PROTECTS MICROSOMES FROM ETHANOL-DERIVED OXIDATIVE STRESS MEDIATED BY CYP2E1
  168. Case Control Study of Genetic Polymorphism of Cytochrome P4502E1 5′(CYP2E1 5′) and Susceptibility of Occupational Manganism [J]
  169. Case-control study of the polymorphisms of CYP2E1-RsaⅠ and GSTT1 genes and susceptibility to pancreatic cancer
  170. CCl 4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat
  171. cDNA sequence, deduced amino acid sequence, predicted gene structure and chemical regulation of mouse CYP2E1
  172. Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology
  173. Changes in coumarin kinetics and subcellular localization of CYP2E1 contribute to bile duct damage and reduce hepatocellular damage after repeated administration …
  174. Changes of CYP2E1 activity in diabetic rat model
  175. Characterization of a dietary ethanol protocol for CYP2E1 induction in the CD-1 mouse without evident hepatic toxicity or genotoxicity
  176. Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1
  177. Characterization of polymorphisms of genes ADH2, ADH3, ALDH2 and CYP2E1 and relationship to the alcoholism in a Colombian population
  178. Chemical characteristics for optimizing CYP2E1 inhibition
  179. CHIP−/−-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications
  180. Chlormethiazole, an inhibitor of CYP2E1, prevented chemical carcinogen-initiated and alcohol-promoted hepatic carcinongenesis in rats.
  181. CYP2E1_Activity_in_Humans/links/54b536b40cf26833efd080d9.pdf”>Chlorzoxazone as a Single Sample Probe of Hepatic CYP2E1 Activity
  182. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans
  183. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1
  184. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts
  185. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans
  186. Chlorzoxazone: An in vitro and in vivo substrate probe for liver CYP2E1
  187. Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats
  188. Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy
  189. Chronic ethanol and high glucose inducible CYP2E1 mediated oxidative stress leads to greater cellular injury in VL-17A cells: a potential mechanism for liver injury …
  190. Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: Role of CYP2E1 and TNF-α and activation of JNK and P38 MAP kinase
  191. Cloning and bioinformatics revealed molecular characterisation of CYP2E1 gene from bactrian camel (Camelus bactrianus)
  192. Cloning and expression of rat CYP2E1 in Saccharomyces cerevisiae: Detection of genotoxicity of N‐alkylformamides
  193. Cloning and sequence analysis of human embryonic nasopharyngeal epithelial CYP2E1 cDNA
  194. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma
  195. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity
  196. Comment on:“Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”
  197. Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches
  198. Comparative metabolism and disposition of trichloroethylene in CYP2E1–/–and wild-type mice
  199. Comparing the protective effects of three sulfur compounds against acrylonitrile-induced acute toxicity in CYP2E1-induced rats
  200. Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humans
  201. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C
  202. Comparison of genetic polymorphisms of CYP2E1, ADH2, and ALDH2 genes involved in alcohol metabolism in Koreans and four other ethnic groups
  203. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect
  204. Comparison of levels of cytochromes P‐450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples
  205. COMPARISON OF POLYMORPHISM rs2070672 CYP2E1 GENE PROPORTION IN EARLY AND ADVANCED STAGE OF UNDIFFERENTIATED TYPE …
  206. CYP2E1-gene-in-various-clinical-stage-of-undifferentiated-type-nasopharyngeal-carcinoma/”>Comparison of Polymorphism rs3813865 Cytochrome P450 Family 2 Subfamily E Polypeptide 1 (CYP2E1) Gene in Various Clinical Stage of Undifferentiated …
  207. Comparison of the polymorphic regions of the cytochrome P450 CYP2E1 gene of humans and patas and cynomolgus monkeys
  208. Comparison of the susceptibility of wild-type and CYP2E1 knockout mice to the hepatotoxic and pneumotoxic effects of styrene and styrene oxide
  209. Compatible effects of euphorbia and glycyrrhiza on CYP2E1 expression and activity in rat liver
  210. Computational Docking Investigations of Oxidative Metabolism of 4-Nitroanisole with CYP2E1
  211. Computational Docking Simulations of Nitroanisole and Nitrophenol with CYP2E1
  212. Computational docking studies of nitroanisoles and nitrophenols with CYP2E1
  213. Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in …
  214. Conformational anti‐cytochrome P4502E1 (CYP2E1) auto‐antibodies contribute to necro‐inflammatory injury in chronic hepatitis C
  215. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice
  216. Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations
  217. Construction and Identification of miRNA Expression Vector Targeting on Mouse CYP2E1
  218. Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order
  219. Construction of CRISPR/Cas9-mediated genomic deletion of the CYP2E1 gene in human HEK293FT cell line
  220. Construction of CYP2E1 recombinant adenovirus vector and its anti-tumor effects
  221. Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis
  222. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
  223. Contribution of CYP2E1 polymorphism to aging in the mechanical workshop workers
  224. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism
  225. Contribution of the ALDH2 and CYP2E1 genes to flushing response and drinking patterns in Japanese healthy volunteers
  226. Contributions of caspase-8 and-9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons
  227. CONTROL OF BOAR TAINT BY USING GENETIC MARKERS: A SINGLE NUCLEOTIDE POLYMORPHISM IN THE CYP2E1 GENE PROMOTER AFFECTS …
  228. Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures
  229. Correction to The Action of Cytochrome b5 on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
  230. Correction to: CYP2E1-mediated oxidative stress regulates HO-1 and GST expression in maneb-and paraquat-treated rat polymorphonuclear leukocytes
  231. Correlation analyses of ALDH2 and CYP2E1 genetic polymorphism with personality
  232. Correlation between genetic polymorphism in CYP2E1, GST and toxicity of dimethylformamide
  233. CORRELATION BETWEEN GENETIC POLYMORPHISM OF CYP2E1 AND SUSCEPTIBILITY OF ESOPHAGEAL CANCER IN GANSU PROVINCE
  234. Correlation between genetic polymorphisms of CYP2E1 DraⅠ and susceptibility of gastric cancer in Qinghai province
  235. Correlation between genetic polymorphisms of CYP2E1 DraⅠ and susceptibility of gastric cancer in Qinghai province [J]
  236. CORRELATION BETWEEN GENETIC POLYMORPHISMS OF CYP2E1 RSAⅠ AND SUSCEPTIBILITY OF GASTRIC CANCER IN QINGHAI PROVINCE [J]
  237. Correlation between spermatogenesis disorders and rat testes CYP2E1 mRNA contents under experimental alcoholism or type I diabetes
  238. Covalent immobilization of recombinant human cytochrome CYP2E1 and glucose-6-phosphate dehydrogenase in alumina membrane for drug screening applications
  239. Covalent modification and time-dependent inhibition of human CYP2E1 by the meta-isomer of acetaminophen
  240. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis
  241. Crosstalk between CYP2E1 and CYP3A enzymes and its Possible Involvement in Alcohol‐Drug Interactions.
  242. Cryopreserved porcine hepatocytes: expression and induction of cytochrome P450, isoform CYP2E1
  243. Cutaneous CYP2E1 induction after topical treatment by dexamethasone, ethanol and salicylic acid in mouse.
  244. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria
  245. CYP17A1 and CYP2E1 variants associated with high altitude polycythemia in Tibetans at the Qinghai-Tibetan Plateau
  246. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir
  247. CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
  248. CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus
  249. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell …
  250. CYP1A1, CYP2E1 and EPHX1 polymorphisms in sporadic colorectal neoplasms
  251. CYP1A1, CYP2E1 and gastric cancer risk in a high-incidence Colombian population
  252. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people
  253. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese
  254. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head …
  255. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small-cell …
  256. CYP1A2* 1C, CYP2E1* 5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients
  257. CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to Oral Submucous Fibrosis among betel quid chewers of Eastern India
  258. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro
  259. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism
  260. CYP2E1
  261. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling
  262. CYP2E1 activity and children with obesity: possible confounding factors
  263. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease
  264. CYP2E1 activity in cisplatin resistant cancer cells
  265. CYP2E1 activity in patients with alcoholic liver disease
  266. CYP2E1 activity on ARPE-19 cells: New approach to RPE ethanol metabolism
  267. CYP2E1 and ALDH2 Gene Polymorphisms in Squamous Cell Head and Neck
  268. CYP2E1 and ALDH2 gene polymorphisms in squamous cell head and neck cancer in the Turkish population
  269. CYP2E1 and ALDH2 genotypes and alcohol dependence in Japanese
  270. CYP2E1_and_catalase_influence_ethanol_sensitivity.7.aspx”>CYP2E1 and catalase influence ethanol sensitivity in the central nervous system
  271. CYP2E1 and clinical features in alcoholics
  272. CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation
  273. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
  274. CYP2E1 and GSTM1 gene polymorphisms, environmental factors, and the susceptibility to lung cancer
  275. CYP2E1 and miRNA‐378a‐3p contribute to acetaminophen‐or tripterygium glycosides‐induced hepatotoxicity
  276. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population
  277. CYP2E1_and_nqo1_genotypes,_smoking_and_bladder.6.aspx”>CYP2E1 and NQO1 genotypes, smoking and bladder cancer
  278. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease
  279. CYP2E1 and oxidative liver injury by alcohol
  280. CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
  281. CYP2E1 and risk of chemically mediated cancers
  282. CYP2E1_and_XRCC1_Genetic_Polymorphisms_and_the.906.aspx”>CYP2E1 and XRCC1 Genetic Polymorphisms and the Risk of Liver Fibrosis in Workers Exposed to Vinyl Chloride Monomer
  283. CYP2E1 autoantibodies in liver diseases
  284. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway
  285. CYP2E1 competes with CYP2B4 for limited NADPH‐Cytochrome P450 Reductase
  286. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90
  287. CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophaghy in HepG2 E47 cells
  288. CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: Relationship with oxidative stress and smoking habit
  289. CYP2E1 expression in bone marrow and its intra-and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk …
  290. CYP2E1 expression in human lymphocytes from various ethnic populations
  291. CYP2E1 Expression in Liver of Type 2 Diabetic Rats [J]
  292. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck
  293. CYP2E1 gene polymorphism and ovarian cancer risk in the Yakut population
  294. CYP2E1 GENE POLYMORPHISM AND SUSCEPTIBILITY OF HEPATOCELLULAR CARCINOMA IN QINGHAI TIBETAN POPULATION
  295. CYP2E1 gene polymorphisms related to the formation of coronary artery lesions in Kawasaki disease
  296. CYP2E1 Gene Promoter Polymorphism -1293G>C Increases the Risk of Essential Hypertension in Men with Alcohol Abuse
  297. CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China
  298. CYP2E1 Genetic Polymorphism relating to Styrene Metabolism of Korean Workers
  299. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
  300. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis
  301. CYP2E1 genotype and transaminase level of tuberculosis patients receiving fixed dose combination of antituberculosis
  302. CYP2E1 genotypes and serum LAP in Japanese alcoholics
  303. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
  304. CYP2E1 hydroxylation of aniline involves negative cooperativity
  305. CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia
  306. CYP2E1 impairs GLUT4 gene expression and function: NRF2 as a possible mediator
  307. CYP2E1 in the human retinal pigment epithelium: expression, activity, and induction by ethanol
  308. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation
  309. CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons
  310. CYP2E1 inhibition enhances mallory body formation
  311. CYP2E1 is a central mediator for the synergistic effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation
  312. CYP2E1 is not involved in early alcohol-induced liver injury
  313. CYP2E1 is preferentially expressed in Clara cells of murine lung: localization by in situ hybridization and immunohistochemical methods.
  314. CYP2E1 level in peripheral lymphocytes correlates with early pathogenesis of diabetic nephropathy.
  315. CYP2E1 level in rat liver injured by the interaction between carbon tetrachloride and chloroform
  316. CYP2E1 mediated ethanol metabolism in ARPE-19 cells.
  317. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats
  318. CYP2E1 Mediates Ethanol-Induced DNA Damage And TNF Release In Bronchial Epithelial Cells
  319. CYP2E1 metabolism of styrene involves allostery
  320. CYP2E1 mRNA expression, genetic polymorphisms in peripheral blood lymphocytes and liver abnormalities in Chinese VCM-exposed workers
  321. CYP2E1 mutation associated with increased chlorzoxazone (CZ) metabolic ability
  322. CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling
  323. CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of γ-glutamylcysteine synthetase
  324. CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells
  325. CYP2E1 overexpression up-regulates both non-specific ô-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1
  326. CYP2E1 overexpression up-regulates both non-specific δ-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1
  327. CYP2E1 phenotype in Mexican workers occupationally exposed to low levels of toluene
  328. CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients
  329. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study
  330. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis
  331. CYP2E1 polymorphisms and gene–environment interactions in the risk of upper aerodigestive tract cancers among Indians
  332. CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis
  333. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis
  334. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment
  335. CYP2E1 potentiation of LPS and TNFα-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases …
  336. CYP2E1 PstI polymorphism increases cervical neoplasia risk: a meta-analysis
  337. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis
  338. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls
  339. CYP2E1 recovery is associated with a pericentral fibrosis pattern after repeated CCl4 insults
  340. CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes
  341. CYP2E1 rs2031920, COMT rs4680 polymorphisms, cigarette smoking, alcohol use and lung cancer risk in a Japanese population
  342. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking
  343. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls
  344. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis
  345. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
  346. CYP2E1 RsaⅠpolymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking
  347. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies
  348. CYP2E1 Rsai/Psti polymorphisms contributed to oral cancer susceptibility: A meta-analysis
  349. CYP2E1 substrate inhibition mechanistic interpretation through an effector site for monocyclic compounds
  350. CYP2E1 substrate inhibition. MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS.
  351. CYP2E1 substrate inhibition..
  352. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls
  353. CYP2E1 VNTR genotyping associated to anti–tuberculosis drug-induced hepatotoxicity
  354. CYP2E1 VNTR polymorphisms and hepatocarcinoma: a gender-specific correlation
  355. CYP2E1* 1D regulatory polymorphism: association with alcohol and nicotine dependence
  356. CYP2E1* 5B, CYP2E1* 6, CYP2E1* 7B, CYP2E1* 2, and CYP2E1* 3 allele frequencies in Iranian populations
  357. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug‐induced hepatotoxicity: a nested case–control study
  358. CYP2E1, oxidative stress and MAPK signaling pathways in alcohol-induced hepatotoxicity
  359. CYP2E1, oxidative stress, post-translational modifications and lipid metabolism
  360. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury
  361. CYP2E1: from ash to nash
  362. CYP2E1: Mechanism of induction by isoniazid and role in acetaminophen oxidation.
  363. CYP2E1: the anesthesia enzyme
  364. CYP2E1-and TNFalpha/LPS-induced oxidative stress and MAPK signaling pathways in alcoholic liver disease
  365. CYP2E1–Biochemical and Toxicological Aspects and Role in Alcohol-Induced Liver Injury
  366. CYP2E1-catalyzed alcohol metabolism: Role of oxidant generation in interferon signaling, antigen presentation and autophagy
  367. CYP2E1-catalyzed oxidation contributes to the sperm toxicity of 1-bromopropane in mice
  368. CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis
  369. CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism
  370. CYP2E1-dependent bioactivation of 1, 1-dichloroethylene in murine lung: formation of reactive intermediates and glutathione conjugates
  371. CYP2E1-dependent bioactivation of 1, 1-dichloroethylene to reactive intermediates in murine and human lung and liver microsomes.
  372. CYP2E1-DEPENDENT BIOACTIVATION OF 191
  373. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid
  374. CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes
  375. CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced liver injury
  376. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells
  377. CYP2E1-dependent toxicity and up-regulation of antioxidant genes
  378. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane
  379. CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
  380. CYP2E1‐mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
  381. CYP2E1-mediated oxidative stress regulates HO-1 and GST expression in maneb-and paraquat-treated rat polymorphonuclear leukocytes
  382. Cytochemical Localization of the Acetone-lnducible Cytochrome P-450 Isoform, CYP2E1 in Murine Colonic Epithelium
  383. Cytochrome b5 coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium
  384. Cytochrome b5 reductase and cytochrome b5 support the CYP2E1-mediated activation of nitrosamines in a recombinant Ames test
  385. Cytochrome CYP2E1 is critical for joint effects of alcohol and lipids on hepatocellular steatosis and inflammation
  386. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments
  387. Cytochrome P450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice
  388. Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice
  389. Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells
  390. Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde–protein adduct in the rat liver
  391. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
  392. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol‐induced oxidative DNA damage in rodent liver
  393. Cytochrome P450 Genes (CYP2E1 and CYP1A1) Variants and Susceptibility to Chronic Hepatitis B Virus Infection
  394. Cytochrome P450 Reductase-null Mice as an Animal Model to Study Electron Transfer Pathways in Cholesterol Synthesis and CYP2E1-mediated Drug Metabolism
  395. Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes
  396. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.
  397. Cytochrome P450IIE1 (CYP2E1) is induced by skatole and this induction is blocked by androstenone in isolated pig hepatocytes
  398. Cytochrome p-450-mediated differential oxidative modification of proteins: albumin, apolipoprotein E, and CYP2E1 as targets
  399. D2-receptor-linked signaling pathways regulate the expression of hepatic CYP2E1
  400. Decreased CYP2E1 mRNA expression in human leucocytes in patients with fibrotic and inflammatory lung diseases
  401. Decreased protein and mRNA expression of ER stress proteins GRP78 and GRP94 in HepG2 cells over-expressing CYP2E1
  402. dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the …
  403. Depletion of cytosolic or mitochondrial thioredoxin increases CYP2E1-induced oxidative stress via an ASK-1–JNK1 pathway in HepG2 cells
  404. Depression of glutathione content, elevation of CYP2E1-dependent activation, and the principal determinant of the fasting-mediated enhancement of 1, 3-dichloro-2 …
  405. Detection and characterization of novel polymorphisms in the CYP2E1 gene.
  406. Detection of autoantibodies against cytochrome P450 2E1 (CYP2E1) in patients with recurrent hepatitis C
  407. Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C
  408. Detection of CYP2E1, a genetic biomarker of susceptibility to benzene metabolism toxicity in immortal human lymphocytes derived from the Han Chinese population
  409. Determination of the activity of human hepatic cytochromes P450 CYP2C8/9, CYP2E1
  410. Development and properties of HepG2 cells that constitutively express CYP2E1
  411. Development of a non-high pressure liquid chromatography assay to determine [14C] chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes
  412. Development of an IgY antibody-based immunoassay for the screening of the CYP2E1 inhibitor/enhancer from herbal medicines
  413. Developmental Expression of CYP2E1 in the Human Liver: Hypermethylation Control of Gene Expression During the Neonatal Period
  414. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality
  415. Diallylsulfide and allylmethylsulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models
  416. Dichloroacetic acid treatment increases hepatic CYP2E1 in male and female rats
  417. Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean
  418. Dietary lipids affect human ethanol-inducible CYP2E1 gene expression in vivo in mononuclear cells
  419. Dietary omega-3 polyunsaturated fatty acids alter fatty acid composition of lipids and CYP2E1 expression in rat liver tissue
  420. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites
  421. Different CYP2E1 genotypes and alcoholic liver disease.
  422. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′-flanking region
  423. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol
  424. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver
  425. Differential effects of dietary fatty acids on the regulation of CYP2E1 and protein kinase C in human hepatoma HepG2 cells
  426. Differential expression of cytochrome P4502E1 (CYP2E1) in Morris hepatomas and livers of tumor bearing rats.
  427. Differential expression profile of cytochrome p450 2E1 (CYP2E1) related genes associated with carbon tetrachloride-induced hepatotoxicity
  428. Differential in vivo effects of α‐naphthoflavone and β‐naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney
  429. Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake
  430. Differential metabolism of acrylonitrile to cyanide is responsible for the greater sensitivity of male vs female mice: role of CYP2E1 and epoxide hydrolases
  431. Differential Modulation of CYP2E1 Activity by cAMP-Dependent Protein Kinase upon Ser129Replacement
  432. Differential role of CYP2E1 binders and isoniazid on CYP2E1 protein modification in NADPH-dependent microsomal oxidative reactions: free radical scavenging …
  433. Differential role of CYP2E1-mediated metabolism in the lethal and vestibulotoxic effects of cis-crotononitrile in the mouse
  434. Diminished CYP2E1 expression and formation of 2-S-glutathionyl acetate, a glutathione conjugate derived from 1, 1-dichloroethylene epoxide, in murine lung tumors
  435. Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic …
  436. Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat
  437. Distribution of ADH1B, ALDH2, CYP2E1∗ 6, and CYP2E1∗ 7B genotypes in Turkish population
  438. Distribution of cytochrome CYP2E1 in murine liver after ethanol and acetone administration
  439. DLPC attenuates alcohol-induced cytotoxicity in HepG2 cells expressing CYP2E1
  440. DNA damage and cytotoxicity in pancreatic β-cells expressing human CYP2E1
  441. DNA damage in peripheral blood lymphocytes and association with polymorphisms in the promoter region of the CYP2E1 gene in alcoholics from Central Brazil
  442. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood …
  443. Do Endogenous Volatile Organic Chemicals Measured in Breath Reflect and Maintain CYP2E1 Levelsin Vivo?
  444. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage
  445. Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?
  446. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies
  447. Downregulation of the CYP2E1 ameliorates oxidative stress and apoptosis
  448. Down-regulation of the expression of alcohol dehydrogenase 4 and CYP2E1 by the combination of α-endosulfan and dioxin in HepaRG human cells
  449. Drinking Water Chlorination By-Products and Intra-Uterine Growth Restriction: is there an effect modification of the CYP2E1 G1259C gene polymorphism?
  450. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans
  451. e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
  452. Early Alcoholic Liver Injury: Formation of Protein Adducts with Acetaldehyde and Lipid Peroxidation Products, and Expression of CYP2E1 AND CYP3A
  453. Effect of {gamma}-irradiation and mitomycin C (MMC) on CYP2B1 and CYP2E1 activities in rat hepatic microsomes in vitro
  454. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats
  455. effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress
  456. Effect of ALDH2 and CYP2E1 Gene Polymorphisms on Drinking Behavior and Alcoholic Liver Disease in Japanese Male Workers
  457. Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-κB activation and CYP2E1 content of rats with immunological liver injury
  458. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes
  459. Effect of BI-1 on insulin resistance through regulation of CYP2E1
  460. Effect of Capsosiphon fulvescens on ethanol-induced liver damage in HepG2 cells over expressing CYP2E1
  461. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N‐acetyltransferase in healthy human subjects
  462. Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung
  463. Effect of CYP2E1 gene deletion in mice on expression of microsomal epoxide hydrolase in response to VCD exposure
  464. Effect of CYP2E1 genetic polymorphisms on susceptibility of aplastic anemia
  465. Effect of CYP2E1 induction by ethanol on the immunotoxicity and genotoxicity of extended low-level benzene exposure
  466. Effect of CYP2E1 polymorphism on DNA stability and lung cancer susceptibility
  467. Effect of CYP2E1 Ras I Genotypes on CYP2E1 Enzyme Activity and DNA Damage of Immortalized Human Lymphocytes Induced by Phenol
  468. Effect of different radix polygoni multiflori preparata on CYP2E1 mRNA expression in rat liver [J]
  469. Effect of disulfiram‐mediated CYP2E1 inhibition on the disposition of vesnarinone
  470. Effect of Er Chen Tang on CYP2E1 and Mitochondrial Energy Metabolism in Nonalcoholic Fatty Liver Disease
  471. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis
  472. Effect of exposure to benzo [a] pyrene on SODs, CYP1A1/1A2-and CYP2E1 immunopositive proteins in the blood clam
  473. Effect of exposure to benzo [a] pyrene on SODs, CYP1A1/1A2-and CYP2E1 immunopositive proteins in the blood clam Scapharca inaequivalvis
  474. Effect of fasting and obesity in humans on the 6‐hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity
  475. Effect of flavonoids extract from apocynum venetum tea on CYP2E1 in mice.
  476. Effect of Ganzheng formula on CYP2E1, adiponectin and TNF-α in NAFLD rats
  477. Effect of Gegen Powder on CYP450 Content of Liver Microsomal and Activity of CYP2E1 in Mice Acute Alcohol-induced Liver Injury
  478. Effect of genetic polymorphisms of toxin metabolic enzyme CYP2E1 on metabolism of styrene
  479. Effect of high‐dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe
  480. Effect of jujube on the expression of CYP2E1 and TNF-alpha in the hepatic tissue of mice with alcoholic liver disease
  481. Effect of Leflunomide on the content of cytochrome P450 enzyme and CYP2E1 mRNA expression of mice with acute chemical injury [J]
  482. Effect of methacrylonitrile on cytochrome P-450 2E1 (CYP2E1) expression in male F344 rats
  483. EFFECT OF NARINGIN ON THE ACTIVITY OF HUMAN LIVER MICROSOMES CYP2E1 USING PROBE DRUG METHOD
  484. Effect of neferine on CYP450 total enzyme and CYP3A1, CYP2D1, CYP2E1 mRNA in Rats
  485. Effect of oleanolic acid on CYP1A2, CYP2E1 and CYP3A4 activity in healthy subjects
  486. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers
  487. Effect of quercetin on CYP1A2, CYP2E1, CYP3A2 activities and its inhibitory mechanism studies in rat liver microsomes
  488. Effect of Salviae Miltiorrhizae Radix et Rhizoma and Carthami Flos before and after compatibility on activities of CYP1A2, CYP2E1, and CYP3A4 from rat liver …
  489. Effect of Sanchi on expression of hepatic CYP2E1 in liver tissues in rats with alcoholic liver disease [J]
  490. Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1
  491. Effect of starvation and acetone on the enzyme systems of biotransformation and toxicity of xenobiotics–CYP2E1 substrates in rats
  492. Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression
  493. Effect of Sulfamethoxazole, Glycyrrhiza Uralensis Fisc and Fisch Fructus Forsythiae on Cytochrome CYP2E1 in Paralichthys Olivaceus by Probe Drugs
  494. Effect of sulfur dioxide inhalation on CYP2B1/2 and CYP2E1 in rat liver and lung
  495. Effect of temperature on carp CYP2E1-like isoform activity.
  496. Effect of TFHL on expression of CYP2E1 in liver tissue of rats with NASH.
  497. Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers
  498. Effect of the South African traditional meat, biltong, on cancer-associated enzymes CYP2E1 and CYP1A2
  499. EFFECT OF TOTAL ALKALOIDES OF ACONITUM EXCELSUM REICHB ON CYP2E1 METABOLISM ACTIVITY IN MORPHINE DEPENDENT RATS [J]
  500. Effect of total alkaloids of Rubus alceaefolius poiron on gene expressions of CYP2E1 and CYP3A1 in rats with acute liver injury
  501. Effect of water miscible organic solvents on p-nitrophenol hydroxylase (CYP2E1) activity in rat liver microsomes
  502. Effect of XiaozhiHugan Capsule on Pathologic Changes and CYP2E1 Gene Expression of Rats with Non-alcoholic Fatty Liver [J]
  503. Effect of γ-irradiation and mitomycin C (MMC) on CYP2B1 and CYP2E1 activities in rat hepatic microsomes in vitro
  504. Effects of acrylamide on oxidant/antioxidant parameters and CYP2E1 expression in rat pancreatic endocrine cells
  505. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1, 3‐dimethyluric …
  506. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans
  507. Effects of aqueous extract of Polygoni Multiflori Radix and its main constituents on expression of mRNA of CYP1A2, CYP2C9, and CYP2E1 in human liver L02 cells
  508. Effects of benzene on liver, kidney and lung cyp1a, cyp2b4, CYP2E1 and cyp3a6 mrna, protein level, and drug metabolizing enzyme activities and toxicity in diabetic …
  509. Effects of blueberry on ultrastructural and expression of cytochrome CYP2E1 in rats with immune hepatic fibrosis
  510. Effects of chlorinated aliphatic hydrocarbons on the fidelity of cell division in human CYP2E1 expressing cells
  511. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma
  512. Effects of Danshen and Its Active Components on Rat CYP2E1 Expression and Metabolism of Model CYP2E1 Probe Substrate
  513. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N …
  514. Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol‐inducible cytochrome P450 (CYP2E1) in the liver of rats …
  515. Effects of Environmental Carcinogens and Genetic Polymorphisms of CYP2E1 and NAT2 on Gastric Carcinogenesis.
  516. Effects of environmental factors on extrahepatic CYP2E1 gene expression in mice
  517. Effects of ethanol on CYP2E1 levels and related oxidative stress using a standard balanced diet
  518. Effects of flavonoids in Lysimachia clethroides duby on the activities of cytochrome P450 CYP2E1 and CYP3A4 in rat liver microsomes
  519. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats
  520. Effects of Ganzhengfufang on the PPARγ and CYP2E1 in the rat with nonalcoholic fatty liver disease
  521. Effects of genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 on the urinary levels of 1-hydroxypyrene and 2-naphthol in aircraft maintenance workers
  522. Effects of GSTM1 and CYP2E1 Genetic Polymorphism and Drinking on DNA Damage among Workers Exposed to Phenol and Acetone
  523. Effects of metadoxine on the expression of CYP2E1 in liver tissue of male rats with alcoholic fat liver [J]
  524. Effects of mitomycin (MMC) and {gamma}-ray irradiation on cytochrome p450 content and activities of CYP2B1 and CYP2E1 in rats
  525. Effects of mitomycin (MMC) and γ-ray irradiation on cytochome p450 content and activities of CYP2B1and CYP2E1 in rats [J]
  526. Effects of mitomycin (MMC) and γ-ray irradiation on cytochrome p450 content and activities of CYP2B1 and CYP2E1 in rats
  527. Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in …
  528. Effects of nonyphenol exposure during pregnant and lactation period on expressions of CYP2E1 mRNA and protein of hepatic tissues in offspring rats
  529. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations
  530. Effects of Purified Glycerol from Biodiesel on Cyp1a1 and CYP2E1 Expressions in CBA/CA Mice
  531. Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats
  532. Effects of SNPs (CYP1B1* 2 G355T, CYP1B1* 3 C4326G, and CYP2E1* 5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han …
  533. Effects of steady-state lasofoxifene on CYP2D6-and CYP2E1-mediated metabolism
  534. EFFECTS OF STRUCTURALLY AND FUNCTIONALLY DIVERSE GROUP OF PHYTOCHEMICALS ON ANILINE HYDROXYLATION (CYP2E1) OF CONTROL AND …
  535. Effects of SU-MIAN-XIN on CYP3A1 and CYP2E1 in Rat Primary Cultured Hepatocytes
  536. Effects of the activities and mRNA level of CYP2E1 in mouse liver microsomal by Folium Isatidis
  537. Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue
  538. Effects of the plant phenolic quercetin on protein and mRNA CYP1A1, CYP2E1, NQO1 and GST enzymes in colon cancer cell line SW620
  539. Effects of Trichloroethylene Toxicity on Normal Human Liver Cells and Hepatocytes With CYP2E1 Gene Overexpression
  540. Effects of Zhenyuan Capsule on Cytochrome P450 Enzymes CYP1A2, CYP3A4 and CYP2E1
  541. Ekspresija CYP2E1 u testisima štakora i alkoholom prouzrokovane promjene indeksa spermatogeneze i kolagena tipa I
  542. Elimination rate of 6-hydroxychlorzoxazone in urine as a non-invasive evaluation of cytochrome CYP2E1 activity. Lack of relationship to smoking
  543. Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer
  544. End-product inhibition of skatole-metabolising enzymes CYP1A, CYP2A19 and CYP2E1 in porcine and piscine hepatic microsomes
  545. Environmental exposure to benzene: evaluation of urinary S-PMA and polymorphism (CYP2E1-1293G> C and NQO1 609C> T) in Campos Elíseos residents …
  546. ‐en‐Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 …
  547. Ephedra water decoction and cough tablets containing ephedra and liquorice induce CYP1A2 but not CYP2E1 hepatic enzymes in rats
  548. Epididymal CYP2E1 plays a critical role in acrylamide-induced DNA damage in spermatozoa and paternally mediated embryonic resorptions
  549. Epilobium hirsutum alters xenobiotic metabolizing CYP1A1, CYP2E1, NQO1 and GPx activities, mRNA and protein levels in rats
  550. Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs
  551. Establishment and toxicological application of a cell line expressing human CYP2E1
  552. Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro
  553. Establishment of model with exogenous human CYP2E1 expression and inducement of substrates
  554. Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol
  555. Ethanol and arachidonic acid produce toxicity in hepatocytes from pyrazole-treated rats with high levels of CYP2E1
  556. Ethanol enhanced the genotoxicity of acrylamide in human, metabolically competent HepG2 cells by CYP2E1 induction and glutathione depletion
  557. CYP2E1_by_protein_stabilization_Role_of_ubiquitin_conjugation_in_the_rapid_degradation_of_CYP2E1/links/58500e2508aed95c250b7b96.pdf”>Ethanol Induces CYP2E1 by Protein Stabilization
  558. Ethanol induces CYP2E1 by protein stabilization role of ubiquitin conjugation in the rapid degradation of CYP2E1
  559. Ethanol induction of CYP2A5: permissive role for CYP2E1
  560. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway
  561. CYP2E1_and_catalase_influence_ethanol_sensitivity.4.aspx”>Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice
  562. Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys
  563. Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341
  564. Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice
  565. Ethanol-induced oxidative stress is associated with EGF receptor phosphorylation in MCF-10A cells overexpressing CYP2E1
  566. Ethanol‐induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes
  567. Ethanol-induction of cytochrome P450 2A5: permissive role for CYP2E1
  568. Ethanol‐mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA‐lesions
  569. Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver
  570. Ethanol‐related cytotoxicity catalyzed by CYP2E1‐dependent generation of reactive oxygen intermediates in transduced HepG2 cells
  571. Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations
  572. CYP2E1_gene__polymorphism.2.aspx”>Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese
  573. Evaluation of activity of hepatic CYP2E1 following administration of Radix et Rhizoma Rhei by probe drug in rats [J]
  574. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations
  575. Evaluation of influence of Andrographis paniculata on activities of CYP1A2, CYP3A4, CYP2E1 and CYP2C19 genotypes in chickens by multiple cytochrome P450 …
  576. Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone
  577. Evidence for the Existence of Two Human CYP2E1 cDNAs Using Different Polyadenylation Signals
  578. Evidence of association of the CYP2E1 genetic polymorphism with micronuclei frequency in human peripheral blood
  579. Evolution of camel CYP2E1 and its associated power of binding toxic industrial chemicals and drugs
  580. Exacerbation of benzene pneumotoxicity in connexin 32 knockout mice: enhanced proliferation of CYP2E1-immunoreactive alveolar epithelial cells
  581. Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse
  582. Experimental study on effect of Erchen decoction and Taohongsiwu decoction on CYP2E1 activities in non-alcoholic fatty liver rats
  583. Experimental study on the effects of combined administration of Shuanghuanglian powder for injection and levofloxacin hydrochloride injection on CYP2E1 in mice
  584. exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 …
  585. Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals
  586. Expression and regulation of cytochrome P450 CYP2E1 in the minipig
  587. Expression of CYP2E1 by human monocyte‐derived macrophages
  588. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples
  589. Expression of CYP2E1 gene in liver tissue in patients with hepatic cirrhosis and obstuctive jaundice
  590. Expression of CYP2E1 gene in paint workers occupationally exposed to organic solvents
  591. Expression of CYP2E1 in Human Lung and Kidney during Development and in Full‐Term Placenta: A Differential Methylation of the Gene is Involved in the …
  592. Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro
  593. Expression of CYP2E1 increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice
  594. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from …
  595. Expression of human CYP2E1 in insect cells using bac-to-bac expression system
  596. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system
  597. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose …
  598. Fast CYP2E1 genotyping using automated fluorescent detection.
  599. Featured structure-activity relationships for some tri-and tetrachlorobiphenyls in human CYP2E1-activated mutagenicity—Impact of the extent of ortho-chlorination
  600. Ferric citrate CYP2E1-independently promotes alcohol-induced apoptosis in HepG2 cells via oxidative/nitrative stress which is attenuated by pretreatment with …
  601. final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: role of CYP2E1 and Keap1-Nrf2 …
  602. for the Expression of Recombinant Human Cytochrome P450s inEscherichia coliUsing Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1
  603. Formation of multiple CYP2E1 complexes affects activity
  604. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations
  605. Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population
  606. Functional analyses of the pig CYP2E1 promoter and identification of the transcription factors required for CYP2E1 expression
  607. CYP2E1_methylation_in.1048.aspx”>Functional correlate of CYP2E1 methylation in chronic exposure to VOCs: promoter methylation vs. 5’UTR methylation
  608. Functional CYP2E1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse
  609. Functional polymorphism in porcine CYP2E1 gene: Its association with skatole levels
  610. Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan population.
  611. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1
  612. Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1
  613. Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1
  614. Gene CYP2E1 expression in mouse liver cells exposed to low-dose radiation
  615. Gene Structure and Multiple Regulations of the Ethanol-Inducible Cytochrome P45O2E1 (CYP2E1) Subfamily
  616. Gene–environmental interactions between alcohol-drinking behavior and ALDH2 and CYP2E1 polymorphisms and their impact on micronuclei frequency in human …
  617. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone
  618. Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs
  619. Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population
  620. Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China
  621. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity
  622. Genetic Polymorphism in Promoter Sequence of CYP2E1 Gene in Paint Manufacturing Workers Exposed to Volatile Organic Compounds
  623. Genetic polymorphism of CYP2D6, CYP2E1 and susceptibility to chronic occupational manganism poisoning [J]
  624. Genetic polymorphism of CYP2E1 and digestive tract alcohol damage among Polish individuals
  625. Genetic polymorphism of CYP2E1, ADH2, and ALDH2 in Mexican-Americans
  626. CYP2E1,_GSTT1_M1_and_NQO1.905.aspx”>Genetic Polymorphism of CYP2E1, GSTT1/M1 and NQO1 on Biomarker of Urinary Spma Among Benzene-Exposed Workers
  627. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter …
  628. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
  629. Genetic polymorphism of human CYP2E1: characterization of two variant alleles
  630. Genetic polymorphism of human CYP2E1: new allels detected in exons and exon-intron junctions
  631. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population
  632. Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson’s disease in Taiwanese
  633. Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population
  634. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the …
  635. Genetic polymorphisms in GSTM1,-P1,-T1, and CYP2E1 and the risk of adult brain tumors
  636. Genetic Polymorphisms of ADH1C and CYP2E1 and Risk of Oral Squamous Cell Carcinoma
  637. Genetic polymorphisms of alcohol inducible CYP2E1 in Turkish population
  638. Genetic Polymorphisms of CYP1A1, CYP2E1, and GSTM1 Genes: Susceptibility to Colon Cancer
  639. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer
  640. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
  641. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer
  642. Genetic polymorphisms of CYP2E1 and GSTM1 and T1 on susceptibility to esophageal cancer in Huaian, China
  643. Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity
  644. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study
  645. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study
  646. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women
  647. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
  648. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population
  649. Genetic Polymorphisms of Genes Coding to Alcohol‐Metabolizing Enzymes in Western Mexicans: Association of CYP2E1*c2/CYP2E1*5B Allele with Cirrhosis and …
  650. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis
  651. Genetic Polymorphisms of NAT2, CYP2C9, CYP2C19, CYP2D6 and CYP2E1, and Antituberculosis Drugs Induced Maculopapular Eruption
  652. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients
  653. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based …
  654. Genetic regulation of liver microsomal CYP2E1 activity among strains of the viviparous fishes Poeciliopsis occidentalis and Poeciliopsis lucida
  655. Genetic Repeat Polymorphism in the Regulating Region of CYP2E1: Frequency and Relationship With Enzymatic Activity in Alcoholics
  656. Genetic Variability in CYP2E1 and Catalase Gene Among Currently and Formerly Alcohol-Dependent Male Subjects
  657. Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population
  658. Genetic variation in the temperature dependence of liver microsomal CYP2E1 activity, within and between species of the viviparous fish Poeciliopsis
  659. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population
  660. Genotoxicity of 1‐methylpyrene and 1‐hydroxymethylpyrene in chinese hamster V79‐derived cells expressing both human CYP2E1 and SULT1A1
  661. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population
  662. Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans
  663. Genotype and allelic frequencies of CYP2E1* 5B polymorphism in the southwest population of Iran
  664. Genotype and phenotype polymorphisms of NAT2 and CYP2E1 in the Han Chinese pediatric population
  665. Genotype Polymorphisms of NAT2 and CYP2E1 Genes Associated with Drug Induced Liver Injury (DILI) in Indonesian Tuberculosis Patients
  666. Global Analysis of Protein− Protein Interactions Reveals Multiple CYP2E1− Reductase Complexes
  667. Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene
  668. Glucose inhibition of the induction of CYP2E1 mRNA expression by ethanol in FGC-4 cells
  669. Glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2
  670. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-κB …
  671. Glycyrrhetinic acid prevents acetaminophen-induced acute liver injury via the inhibition of CYP2E1 expression and HMGB1-TLR4 signal activation in mice
  672. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity
  673. Growth retardation of fetal rats exposed to nicotine in utero: Possible involvement of CYP1A1, CYP2E1, and P‐glycoprotein
  674. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia.
  675. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population
  676. GYKI-47261, a new AMPA [2-amino-3-(3-hydroxymethylisoxazole-4-yl) propionic acid] antagonist, is a CYP2E1 inducer
  677. Halothane inhalation inhibits the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits
  678. HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells
  679. Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years
  680. Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice
  681. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
  682. Hepatoprotective effect of 10% ethanolic extract from Curdrania tricuspidata leaves against ethanol-induced oxidative stress through suppression of CYP2E1
  683. Hepatoprotective Effect of Punica granatum Seed Oil Extract on Paracetamol Intoxication in Rat Via Inhibory Effect of CYP2E1
  684. Hepatotoxicity Mediated by Pyrazole (CYP2E1) Plus TNF-α Treatment Occurs in jnk2−/− but not in jnk1−/− Mice
  685. Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions
  686. High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype
  687. High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines
  688. High dose lycopene supplementation increases hepatic CYP2E1 protein and TNF‐α expression in alcohol fed rats
  689. High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single strand breaks
  690. Higher sensitivity of female cells to ethanol: methylation of DNA lowers CYP2E1, generating more ROS
  691. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1
  692. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells
  693. Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme–substrate and enzyme–inhibitor interactions
  694. Hormone controlled phosphorylation and degradation of CYP2B1 and CYP2E1 in isolated rat hepatocytes
  695. How mutations affecting the ligand-receptor interactions: a combined MD and QM/MM calculation on CYP2E1 and its two mutants
  696. Human CYP2A6, CYP2B6, and CYP2E1 atropselectively metabolize polychlorinated biphenyls to hydroxylated metabolites
  697. Human CYP2E1 is regulated by miR-378
  698. Human CYP2E1 mediates the formation of glycidamide from acrylamide
  699. Human CYP2E1-activated mutagenicity of dioxin-like PCBs 105 and 118—Experimental data consistent with molecular docking results
  700. Human CYP2E1-dependent and human sulfotransferase 1A1-modulated induction of micronuclei by benzene and its hydroxylated metabolites in Chinese hamster …
  701. Human CYP2E1‐dependent mutagenicity of benzene and its hydroxylated metabolites in V79‐derived cells: Suppression and enhancement by ethanol pretreatment
  702. Human CYP2E1-dependent mutagenicity of mono-and dichlorobiphenyls in Chinese hamster (V79)-derived cells
  703. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype.
  704. Human hepatic CYP2E1 expression during development
  705. Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition
  706. Human placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes
  707. Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation)
  708. Hypomethylation and hypoexpression of human CYP2E1 gene in lung tumors
  709. Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1)
  710. Identification and functional analysis of a novel human CYP2E1 far upstream enhancer
  711. Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping
  712. Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin
  713. Identification of a critical CYP2E1 epitope in patients with drug-induced liver injury from anesthetics (93.16)
  714. Identification of CYP2E1 in marmoset monkey
  715. Identification of CYP2E1-dependent genes involved in carbon tetrachloride-induced hepatotoxicity
  716. Identification of cytochrome CYP2E1 as critical mediator of alcohol effects on steatotic hepatocytes
  717. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro
  718. Identification of deletions and duplications in the CYP2E1 gene in a population in Goiânia–GO by MLPA.
  719. Identification of inhibitory component in cinnamon—o-methoxycinnamaldehyde inhibits cyp1a2 and CYP2E1—
  720. Identification of Novel CYP2E1 Inhibitor to Investigate Cellular and Exosomal CYP2E1-Mediated Toxicity
  721. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and CYP2E1-null …
  722. Identification of sequences responsible for intracellular targeting and membrane binding of rat CYP2E1 in yeast
  723. IL-4 promotes experimental drug-induced hepatitis by reducing immune responses to haptenated proteins and inhibiting regulatory responses to native CYP2E1 …
  724. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways
  725. Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues
  726. Immunohistochemical Detection of CYP2E1 and 2-S-Glutathionyl Acetate in Murine Lung Tumors: Diminished Formation of Reactive Intermediates of 1,1 …
  727. Immunohistochemical study of CYP2E1 in hepatocellular carcinoma carcinogenesis: examination with newly prepared anti-human CYP2E1 antibody
  728. Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting
  729. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients
  730. Impact of CYP2E1 polymorphisms on the risk of esophageal cancer
  731. Impact of CYP2E1, GSTA1 and GSTP1 gene variants on serum alpha glutathione S-transferase level in patients undergoing anaesthesia
  732. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver
  733. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma
  734. in rats induced by aqueous extract of Polygoni Multiflori Radix, root of Polygonum multiflorum related to the activity inhibition of CYP1A2 or CYP2E1
  735. in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): The role of urea in CYP2E1 induction by acute …
  736. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV …
  737. In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent
  738. In vitro metabolism of styrene to styrene oxide in liver and lung of CYP2E1 knockout mice
  739. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment
  740. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.
  741. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene
  742. Inactivation of cytochrome P-450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes by vinyl carbamate in murine pulmonary microsomes
  743. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone
  744. Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity
  745. Increase expression of CYP2E1 mRNA after methamphetamine administration in rats
  746. Increased bioaccumulation of urethane in CYP2E1-/-versus CYP2E1+/+ mice
  747. Increased Expression of CYP2E1 gene in gastric cancer may be a molecular marker for mazandaran province population
  748. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
  749. Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co‐expressing HCV core protein and CYP2E1
  750. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1
  751. Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys
  752. Individual variability of CYP2E1 xenobiotic oxidation in human liver
  753. Induction and recovery time course of rat brain CYP2E1 after nicotine treatment
  754. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
  755. Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem
  756. Induction of brain CYP2E1 changes the effects of ethanol on dopamine release in nucleus accumbens shell
  757. Induction of catalase, alpha, and microsomal glutathione S‐transferase in CYP2E1 overexpressing HepG2 cells and protection against short‐term oxidative stress
  758. Induction of CYP1A1 and CYP2E1 in rat liver by histamine: binding and kinetic studies
  759. Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium
  760. Induction of CYP2E1 activity in Ctenopharyngodon idellus hepatocyte
  761. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6‐hydroxylation
  762. Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half …
  763. Induction of CYP2E1 in non-alcoholic fatty liver diseases
  764. Induction of CYP2E1 in testes of isoniazid-treated rats as possible cause of testicular disorders
  765. Induction of DNA strand breaks and oxidative stress in HeLa cells by ethanol is dependent on CYP2E1 expression
  766. Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation
  767. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications
  768. Induction of rat hepatic CYP2E1 expression by arecoline in vivo
  769. Induction of SIRT1 by melatonin improves alcohol‐mediated oxidative liver injury by disrupting the CRBN‐YY1‐CYP2E1 signaling pathway
  770. Influence of Acarbose, Metformin and Pioglitazone on TNF-αand CYP2E1 in Liver Tissue of NAFLD Rat
  771. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro
  772. INFLUENCE OF GENETIC ADMIXTURE ON POLYMORPHISMS OF ALCOHOL-METABOLIZING ENZYMES: ANALYSES OF MUTATIONS ON THE CYP2E1, ADH2, ADH3 AND …
  773. Influence of genetic admixture on polymorphisms of drug‐metabolizing enzymes: Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic …
  774. Influence of GSTs, CYP2E1 and mEH polymorphisms on 1, 3-butadiene-induced micronucleus frequency in Chinese workers
  775. Influence of GSTT1, mEH, CYP2E1 and RAD51 polymorphisms on diepoxybutane-induced SCE frequency in cultured human lymphocytes
  776. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans
  777. Influence of selected inhibitors on the metabolism of the styrene metabolite 4-vinylphenol in wild-type and CYP2E1 knockout mice
  778. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and …
  779. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress
  780. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single-dose watercress ingestion; comparison with one week isoniazid treatment
  781. Inhibition of CYP2E1 activity does not abolish pulsatile urine alcohol concentrations during chronic alcohol infusions
  782. Inhibition of CYP2E1 and activation of Nrf2 signaling pathways by a fraction from Entada africana alleviate carbon tetrachloride-induced hepatotoxicity
  783. Inhibition of CYP2E1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction and apoptosis
  784. Inhibition of CYP2E1 attenuates myocardial dysfunction in a murine model of insulin resistance through NLRP3-mediated regulation of mitophagy
  785. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
  786. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine
  787. CYP2E1-expression-by-androstenone-relation-to-boar-taint”>Inhibition of CYP2E1 expression by androstenone: Relation to boar taint
  788. Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells
  789. Inhibition of CYP2E1 leads to decreased malondialdehyde–acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposure
  790. Inhibition of CYP2E1 Reverses CD4+ T-Cell Alterations in Trichloroethylene-Treated MRL+/+ Mice
  791. Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol
  792. Inhibition of CYP2E1 With Propylene Glycol Does Not Protect Against Hepatocellular Injury in Human Acetaminophen Daily‐Dosing Model
  793. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
  794. Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors
  795. Inhibition of Ethanol-induced CYP2E1 by Curcuma longa L. Extract
  796. Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced …
  797. Inhibition of Urethane-Induced Carcinogenicity in CYP2E1−/− in Comparison to CYP2E1+/+ Mice
  798. Inhibition of Urethane-Induced Carcinogenicity in CYP2E1-/-Vs. CYP2E1+/+ Mice
  799. Inhibition of urethane-induced genotoxicity and cell proliferation in CYP2E1-null mice
  800. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots
  801. Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity
  802. Insertion polymorphism of CYP2E1 and urinary N -methylformamide after N,N - dimethylformamide exposure in Japanese workers
  803. Insertion Polymorphism of the CYP2E1 Gene in Patients with Infiltrative Pulmonary Tuberculosis from Bashkortostan
  804. Insertional polymorphism of the CYP2E1 gene in infiltrative pulmonary tuberculosis in populations of Bashkortostan Republic
  805. Insights into insulin-mediated regulation of CYP2E1: miR 132/212 targeting of CYP2E1 and role of PI3-K, Akt, mTOR signaling in regulating miR132/212 and miR 122 …
  806. Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian …
  807. Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes
  808. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression
  809. Interaction between genetic polymorphisms of CYP2E1 & NAT1 and smoking in lung cancer development (Preliminary report)
  810. Interaction between Polymorphisms in CYP2E1 Rsa Ⅰ Genotypes and Lifestyle with Risk of Stomach Cancer
  811. Interaction of polymorphisms of CYP2E1 and environmental risk factors in gastric cancer
  812. Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolism
  813. Interactions between CYP2E1, GSTZ1 and GSTT1 polymorphisms and exposure to drinking water trihalomethanes and their association with semen quality
  814. Interindividual variability of chlorzoxazone 6‐hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms
  815. Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3
  816. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness
  817. Investigation of bioactivation and toxicity of styrene in CYP2E1 transgenic cells
  818. Investigation of indazole unbinding pathways in CYP2E1 by molecular dynamics simulations
  819. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail in vitro with emphasis on CYP2E1
  820. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using CYP2E1-/-mice
  821. In-Vitro CYP3A4, CYP2E1 and UGT Activity in Human Liver Microsomes by Strobilanthes crispus Leaf Extracts
  822. Involvement of CYP2E1 and carboxylesterase enzymes in vinyl carbamate metabolism in human lung microsomes
  823. Involvement of CYP2E1 as a low-affinity enzyme in phenacetin O-deethylation in human liver microsomes
  824. Involvement of CYP2E1 in the course of brain edema induced by subacute poisoning with 1, 2-Dichloroethane in mice
  825. Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism
  826. Iron and CYP2E1-dependent oxidative stress and toxicity
  827. Isolation of the mouse cytochrome P450J (CYP2E1) cDNA and its reciprocal testosterone regulation in kidney and liver
  828. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes
  829. Kaempferol’s protective effect on ethanol-induced mouse primary hepatocytes injury involved in the synchronous inhibition of SP1, Hsp70 and CYP2E1
  830. Kinetic characterization of CYP2E1 inhibition in vivo and in vitro by the chloroethylenes
  831. Kinetic characterizations of diallyl sulfide analogs for their novel role as CYP2E1 enzyme inhibitors
  832. Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver
  833. Lack of association of CYP2E1 and CYP1A1 polymorphisms with osteoporosis in postmenauposal women
  834. Lack of common mutation in the alfa-subunit of the mitochondrial trifunctional protein and the polymorphism of CYP2E1 in three Japanese women with acute fatty liver …
  835. Lack of correlation between lymphocytic mrna expression and activity of CYP3A4 and CYP2E1 In‐vivo in alcoholics and non‐alcoholics
  836. Lack of cytochrome P450 2E1 (CYP2E1) induction in the rat liver by starvation without coprophagy
  837. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats
  838. Lipopolysaccharide induces CYP2E1 in astrocytes through MAP kinase kinase-3 and C/EBPβ and-δ
  839. Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole
  840. Liver cancer-related gene CYP2E1 expression in HBV transgenic mice with acute liver injury
  841. Liver nuclear and microsomal CYP2E1-mediated metabolism of xenobiotics in rats chronically drinking an alcohol-containing liquid diet
  842. Losartan effects on liver cytochromes CYP3A, CYP2C and CYP2E1 functioning at metabolic syndrome in young and adult rats
  843. Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity
  844. Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK
  845. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver
  846. Low-dose diethyldithiocarbamate attenuates the hepatotoxicity of 1, 3-dichloro-2-propanol and selectively inhibits CYP2E1 activity in the rat
  847. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
  848. Lycopene attenuates alcoholic apoptosis in HepG2 cells expressing CYP2E1
  849. Lycopene attenuates arachidonic acid toxicity in HepG2 cells overexpressing CYP2E1
  850. Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects
  851. M1 Polarization bias and subsequent NASH progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1 induced oxidative stress in …
  852. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro
  853. Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats
  854. Mammalian CYP2E1 gene triggered changes of relative ions fluxes, CaM content and genes expression profiles in Petunia hybrida cells to enhance resistance to …
  855. Mammalian cytochrome CYP2E1 triggered differential gene regulation in response to trichloroethylene (TCE) in a transgenic poplar
  856. Mannan‐binding lectin attenuates acetaminophen‐induced hepatotoxicity by regulating CYP2E1 expression via ROS‐dependent JNK/SP1 pathway
  857. Maternal protein restriction during lactation modulated the expression and activity of rat offspring hepatic CYP1A1, CYP1A2, CYP2B1, CYP2B2, and CYP2E1 …
  858. MATERNAL SMOKING, POLYMORPHISMS IN CYP1A1, CYP2E1, EPHX1, NAT2, NQO1, AND CHILDHOOD ACUTE LEUKEMIA
  859. Mechanism and clinical significance of HBx-mediated inhibition of CYP2E1 expression in the human HepG2 hepatoma cell line
  860. mechanism of Wu-Zi-Yan-Zong-Wan, a traditional Chinese herbal formula, against alcohol-induced oxidative damage in CYP2E1 cDNA-transfected HepG2 (E47) …
  861. Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate
  862. Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells
  863. Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis
  864. Meta-analysis on the relationship between CYP2E1 genetic polymorphism and susceptibility to hepatocellular carcinoma in Chinese
  865. Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia
  866. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1
  867. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH …
  868. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1
  869. Metabolic activities of cytochrome P-450 CYP2E1 and cytochrome P-450 CYP3A in hepatic alcohol-injuried rats [J]
  870. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
  871. Metabolism and toxicity of the styrene metabolite 4-vinylphenol in CYP2E1 knockout mice
  872. Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression
  873. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo
  874. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A
  875. Metallothionein 2A induction by zinc protects HEPG2 cells against CYP2E1-dependent toxicity
  876. Method for in vivo and in vitro Evaluation of CYP2E1 Activities
  877. Methodology to assay CYP2E1 mixed function oxidase catalytic activity and its induction
  878. MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity
  879. MicroRNA‐122 protects mice and human hepatocytes from acetaminophen toxicity by regulating CYP1A2 and CYP2E1 expression
  880. Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1.
  881. Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen
  882. Mitochondrial dysfunction by γ-irradiation accompanies the induction of cytochrome P450 2E1 (CYP2E1) in rat liver
  883. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene
  884. Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high‐risk …
  885. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients
  886. Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring
  887. Modulation of ethanol-mediated CYP2E1 induction by clofibrate and L-carnitine in rat liver
  888. Modulation of mouse P450 isoforms CYP1A2, CYP2B10, CYP2E1, and CYP3A by the environmental chemicals mirex, 2, 2-bis (p-chlorophenyl)-1, 1-dichloroethylene …
  889. Modulation of mRNA expression and activities of xenobiotic metabolizing enzymes, CYP1A1, CYP1A2, CYP2E1, GPx and GSTP1 by the Salicornia freitagii extract in …
  890. Molecular cloning and sequence analysis of hamster CYP2E1
  891. Molecular dynamics simulations of CYP2E1
  892. Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1
  893. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and …
  894. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the …
  895. Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen
  896. mRNA Expression of CYP2E1, CYP2A19, CYP1A2, HSD3B, SULT1A1 and SULT2A1 genes in surgically castrated, immunologically castrated, entire male and female …
  897. Multifold Activation of CYP3A4 Caused by Alcohol-Induced Increase in the Content of CYP2E1 in Human Liver Microsomes
  898. Mutagenic Activity of N‐Nitrosodiethylamine in Cell Lines Expressing Human CYP2E1—Adequacy of Dimethylsulfoxide as Solvent
  899. NADPH: CYTOCHROME P450 REDUCTASES OF VARIOUS SPECIES CAN BE USED IN SYSTEMS RECONSTITUTING DRUG-METABOLIZING CYP2E1 …
  900. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species
  901. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver
  902. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis
  903. NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption
  904. NF-κB-mediated regulation of rat CYP2E1 by two independent signaling pathways
  905. N-Hydroxylation of 4-Aminobiphenyl by CYP2E1 Produces Oxidative Stress in a Mouse Model of Chemically Induced Liver Cancer
  906. Nicotinamide N-oxidation by CYP2E1 in human liver microsomes
  907. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity
  908. No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into …
  909. No association of CYP2E1 genetic polymorphisms with alcohol dependence in Han Taiwanese population
  910. No linkage of the cytochrome P-450IIE1 (CYP2E1) C1/C2 polymorphism to schizophrenia
  911. No significant expression of CYP2E1 in rat liver stellate cells
  912. Non-additive effects of changing the cytochrome P450 ensemble: incorporation of CYP2E1 into human liver microsomes and its impact on CYP1A2
  913. Noninvolvement of CYP2E1 in the (ω-1)-hydroxylation of fatty acids in rat kidney microsomes
  914. Non-positive autoimmune responses against CYP2E1 in refrigeration mechanics exposed to halogenated hydrocarbons
  915. Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer risk
  916. Novel CYP2E1 haplotype identified in a South African cohort
  917. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure—a literature review
  918. Nrf2 and antioxidant defense against CYP2E1 toxicity
  919. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1
  920. Obesity‐induced CYP2E1 activity in children
  921. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats
  922. of human prenatal biosynthesis of all-trans-retinoic acid by ethanol, ethanol metabolites, and products of lipid peroxidation reactions: a possible role for CYP2E1
  923. of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 …
  924. of the accumulation of acetaldehyde from ethanol in human prenatal cephalic tissues: evaluation of the relative contributions of CYP2E1, alcohol dehydrogenase, and …
  925. OF THE PLANT PHENOLIC QUERCETIN ON PROTEIN AND mRNA EXPRESSIONS OF XENOBIOTIC METABOLIZING CYP1A1, CYP2E1, NQO1 AND GST …
  926. of twelve chlorinated aliphatic hydrocarbons upon the cell cycle of Chinese hamster cell lines: V79d-MZ and genetically engineered cell lines expressing CYP2E1
  927. Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat
  928. Ontogeny of rat CYP2E1 and CYP1A2: a characterization and a pharmacokinetic model
  929. Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells
  930. Opposite effects of isoniazid and fasting on the expression of CYP2E1 protein and mRNA in house musk shrew (Suncus murinus)
  931. Oral clefts, maternal exposure to solvents and CYP2E1 polymorphism
  932. overexpression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP2E1
  933. Overexpression of CYP2E1 enhances sensitivity of hepG2 cells to fas-mediated cytotoxicity
  934. Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione
  935. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5′-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR)
  936. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv (16)(p13. 1q22); …
  937. Oxidative stress caused by a SOD1 deficiency ameliorates thioacetamide-triggered cell death via CYP2E1 inhibition but stimulates liver steatosis
  938. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1
  939. Oxidative stress potentiated by diallylsulfide, a selective CYP2E1 inhibitor, in isoniazid toxic effect on rat primary hepatocytes
  940. Oxidative stress, toxicology, and pharmacology of CYP2E1
  941. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
  942. Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression
  943. patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, CYP2E1, gstm1 and gstt1
  944. Persimmon vinegar and its fractions protect against alcohol-induced hepatic injury in rats through the suppression of CYP2E1 expression
  945. Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization
  946. Pharmacokinetics of chlorzoxazone in rats with diabetes: induction of CYP2E1 on 6-hydroxychlorzoxazone formation
  947. Pharmacokinetics of drug interactions due to ligand stabilization of CYP2E1.
  948. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1, 3-dimethyluric acid formation
  949. Pharmacological blockage of CYP2E1 and alcohol-mediated liver cancer: is the time ready?
  950. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism
  951. Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population
  952. Phorbol ester induces CYP2E1 in astrocytes, through a protein kinase C‐and tyrosine kinase‐dependent mechanism
  953. Phosphorylation of cytochrome P4502E1 (CYP2E1) by calmodulin dependent protein kinase protein kinase C and cAMP dependent protein kinase
  954. Phyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: involvement of cytochrome P450 CYP2E1
  955. PI3K inhibitors reverse the suppressive actions of insulin on CYP2E1 expression by activating stress-response pathways in primary rat hepatocytes
  956. Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study
  957. Plasma exosomes exacerbate alcohol-and acetaminophen-induced toxicity via CYP2E1 pathway
  958. Polimorfismos en los genes de la enzima alcohol deshidrogenasa (ADH1) y la citocromo P450 2E1 (CYP2E1) en pacientes con cirrosis y carcinoma …
  959. Polimorfismos nos genes NAT2, CYP2E1, GSTT1, GSTM1 e ABCB11 e hepatotoxicidade induzida pela isoniazida
  960. Polydatin protects rat liver against ethanol-induced injury: involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-B p65 pathway
  961. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users
  962. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers …
  963. Polymorphism of CYP2E1 gene and the risk of lung cancer among African-Americans and Caucasians in Los Angeles County (California).
  964. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma
  965. Polymorphism of the 5′‐Flanking Region of the CYP2E1 Gene: An Association Study With Alcoholism
  966. Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity
  967. Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility
  968. Polymorphisms in glutathione S‐transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or …
  969. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer …
  970. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-products, and Risk of Bladder Cancer in Spain
  971. Polymorphisms in NEIL-2, APE-1, CYP2E1 and mdm2 genes are independent predictors of gastric cancer Risk in a Northern Jiangsu Population (China)
  972. Polymorphisms in the CYP2E1 and GSTM1 genes as possible protection factors for leprosy patients
  973. Polymorphisms of ADH2, ALDH2 and CYP2E1 in huichol and Mestizo subjects from western México in comparison with other populations of the world
  974. Polymorphisms of Alcohol Metabolizing Enzymes in Indigenous Mexican Population: Unusual High Frequency of CYP2E1*c2 Allele
  975. Polymorphisms of CYP1a1, CYP2E1, GSTM1, GSTT1, and TP53 genes in Amerindians
  976. Polymorphisms of CYP2E1 rs2031920 is not Associated with Risk of Nasopharyngeal Carcinoma in Minangkabau Ethnic Group
  977. Polymorphisms of drug-metabolizing enzyme CYP2E1 in Chinese Uygur population
  978. Polymorphisms of GSTP1 and GSTT1 , but not of CYP2A6 , CYP2E1 or GSTM1 , modify the …
  979. Polymorphisms of NAT2, CYP2E1, GST, and HLA Related to Drug‑Induced Liver Injury in Indonesian Tuberculosis Patients
  980. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk
  981. Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case–control study
  982. Polymorphisms of the Cytochrome P450 (CYP1A1, CYP2E1) and Microsomal Epoxide Hydrolase (mEPHX) Genes in Cystic Fibrosis and Chronic Respiratory …
  983. Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system
  984. Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile
  985. Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability
  986. Potent mutagenicity of some non-planar tri-and tetrachlorinated biphenyls in mammalian cells, human CYP2E1 being a major activating enzyme
  987. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1
  988. Povezanost polimorfizama gena TP53 i CYP2E1* 5B s nemikrocelularnim karcinomom pluća
  989. Prediction of The Needs for Benzene Detox with Foods Intake Containing CYP2E1 Enzyme, Sulfation, and Glutathione at Gas Stations Pancoranmas Depok …
  990. Preliminary effects of alcohol and Curcuma longa upon CYP2E1 and hematotoxicity in benzene-induced mice
  991. Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates
  992. Pretreatment with turmeric modulates the inhibitory influence of cisplatin and paclitaxel on CYP2E1 and CYP3A1/2 in isolated rat hepatic microsomes
  993. Progress of research on characteristics of cytochrome P-450 CYP2E1 in protein structure and regulation mechanisms
  994. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2
  995. Proteasome inhibition potentiates CYP2E1‐mediated toxicity in HepG2 cells
  996. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice
  997. Protective Effect of Curcumin on Acrylamide-Induced Hepatic and Renal Impairment in Rats: Involvement of CYP2E1
  998. Protective effect of Ornithogalum saundersiae Ait (Liliaceae) against acetaminophen-induced acute liver injury via CYP2E1 and HIF-1α
  999. Protective Effects of CYP2E1 Inhibitors on Metabolic Syndrome-induced Liver Injury in Guinea Pigs
  1000. Protective effects of diallyl disulfide against acetaminophen-induced nephrotoxicity: a possible role of CYP2E1 and NF-κB
  1001. Protective effects of emodin and chrysophanol isolated from marine fungus Aspergillus sp. on ethanol-induced toxicity in HepG2/CYP2E1 cells
  1002. Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats
  1003. Protective effects of loquat (Eriobotrya japonica) leaves against ethanol-induced toxicity in HepG2 cells transfected with CYP2E1
  1004. Protective effects of protein hydrolysate from marine microalgae Navicula incerta on ethanol-induced toxicity in HepG2/CYP2E1 cells
  1005. Protein kinase C signaling as a survival pathway against CYP2E1-derived oxidative stress and toxicity in HepG2 cells
  1006. Proteomics of oxidative stress using inducible CYP2E1 expressing HEPG2 cells and 3T3-L1 adipocytes as model systems
  1007. psychosocial deprivation in early childhood is associated with increased DNA methylation across a region spanning the transcription start site of CYP2E1
  1008. Pulmonary bioactivation of 1, 1-dichloroethylene is associated with CYP2E1 levels in A/J, CD-1, and C57BL/6 mice
  1009. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1
  1010. Pulmonary CYP2E1 bioactivates 1, 1-dichloroethylene in male and female mice.
  1011. Pulsatile blood alcohol and CYP2E1 induction during chronic alcohol infusions in rats
  1012. Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency
  1013. Quantification of CYP2E1 in rat liver by UPLC-MS/MS-based targeted proteomics assay: a novel approach for enzyme activity assessment
  1014. Quantification of Metabolic Reaction Products Catalysed by CYP2E1 Enzyme Activity: Inhibitory Effect of Cytochrome P450 Enzyme CYP2E1 by Salicylic Acid in Rat …
  1015. Quercetin prevents type 1 diabetic liver damage through inhibition of CYP2E1
  1016. Quercetin suppressed CYP2E1-dependent ethanol hepatotoxicity via depleting heme pool and releasing CO
  1017. Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe …
  1018. Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats
  1019. Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism
  1020. Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and CYP2E1 expression levels
  1021. Red meat intake, CYP2E1 and PPARγ polymorphisms, and colorectal cancer risk
  1022. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk
  1023. Reduced systemic toxicity and preserved vestibular toxicity following co-treatment with nitriles and CYP2E1 inhibitors: a mouse model for hair cell loss
  1024. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression
  1025. Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine
  1026. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes
  1027. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling
  1028. Regulation of X-Ray Irradiation on the Activity and Expression Levels of CYP1A2 and CYP2E1 in Rats
  1029. Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia
  1030. Relationship among Qi-deficiency constitution and CYP2E1 gene polymorphisms and anti-tuberculosis drug-induced hepatitis
  1031. Relationship between alcoholism and CYP2E1 C/D polymorphism
  1032. Relationship between alcoholism and CYP2E1 genotypes
  1033. Relationship between CYP2E1 polymorphism and increase of ALT activity during therapy of patients with pulmonary tuberculosis
  1034. Relationship between CYP2E1, GSTT1 genetic polymorphisms and susceptibility to gastric cancer
  1035. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is …
  1036. Relationship between gene polymorphism of CYP2E1, CYP1A1, IL-4 and medicamentosa-like dermatitis induced by trichloroethylene
  1037. Relationship between genetic polymorphism of CYP2E1 and ALDH2, and possible susceptibility to alcoholism
  1038. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP1B1, CYP2E1, GSTM1, GSTT1, and NAT2) and p53 gene point mutations …
  1039. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 …
  1040. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh’s esophageal squamous cell cancer in Xinjiang
  1041. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh’s esophageal squamous cell cancer in Xinjiang, China
  1042. Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver
  1043. CYP2E1.8.aspx”>Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxyIation of chlorzoxazone: a putative measure of CYP2E1 activity
  1044. Relationship of ALDH2 rs671 and CYP2E1 rs2031920 with hepatocellular carcinoma susceptibility in East Asians: a meta-analysis
  1045. Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
  1046. Relationship of CYP2E1 RsaⅠ genetic polymorphism and smoking, alcohol drinking habit with risk of rectal cancer
  1047. Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug …
  1048. RELATIONSHIPS BETWEEN GENETIC POLYMORPHISMS IN CYP2D6 AND CYP2E1 GENES AND LIVER MICROSOMAL DRUG OXIDATION ACTIVITIES
  1049. Relative contributions of CYP1A2 and CYP2E1 to the bioactivation and clearance of 4-aminobiphenyl in adult mice
  1050. Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone
  1051. Relevance of CYP2E1 to non-alcoholic fatty liver disease
  1052. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1
  1053. Renal and hepatic accumulation of cadmium and lead in the expression of CYP4F2 and CYP2E1
  1054. Requirement Prediction for Toluene Detox with Foods Intake Rich in CYP2E1 Enzyme and Glycine to Prevent Nerve and Kidney Damage at Shoe Home …
  1055. Research on Association of Genetic Polymorphism of CYP1A1 and CYP2E1, with Susceptibility to Gastric Cancer
  1056. Research on the progress of alcoholic liver disease pathogenesis related to CYP2E1
  1057. Research on the relationship between ALDH2 and CYP2E1 gene polymorphism and alcoholic liver disease in Han people
  1058. Research on the relationship between polymorphism of CYP2E1 and dermatitis medicamentosa-like of trichloroethylene [J]
  1059. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression
  1060. Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?
  1061. RESULTS OF INTENSIVE PHASE TRETAMENT OF TUBERCULOSIS TREATMENT ACCORDING TO CYP2E1 GENOTYPE
  1062. Resveratrol downregulates CYP2E1 and attenuates chemically induced hepatocarcinogenesis in SD rats
  1063. Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers
  1064. Rifampicin suppresses hepatic CYP2E1 expression and minimizes DNA injury caused by carbon tetrachloride in perivenular hepatocytes of mice
  1065. Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1
  1066. Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme
  1067. Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability
  1068. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development
  1069. Role of brain acetaldehyde in drinking preference: genetic modification of alcohol oxidizing enzymes catalase and CYP2E1 in C57BL/6 mice and their …
  1070. Role of calcium and calcium-activated proteases in CYP2E1-dependent toxicity in HEPG2 cells
  1071. Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction
  1072. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias
  1073. Role of CYP2E1 (PstI/RsaI) gene polymorphisms on the tacrolimus drug toxicity of kidney transplantations among South Indians
  1074. Role of CYP2E1 activity in endoplasmic reticulum ubiquitination, proteasome association, and the unfolded protein response
  1075. Role of CYP2E1 and NQO1 polymorphisms in oxidative stress derived cancer in Thais with and without dyslipidemia
  1076. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital
  1077. Role of CYP2E1 gene polymorphisms association with hepatitis risk in Northeast India
  1078. Role of CYP2E1 Immunoglobulin G4
  1079. Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis
  1080. Role of CYP2E1 in deramciclane metabolism
  1081. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo
  1082. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity
  1083. Role of CYP2E1 in Impaired Nitric Oxide Synthase (NOS)‐Dependent Cerebral Vasodilation During Chronic Alcohol Consumption
  1084. Role of CYP2E1 in ketone-stimulated insulin release in pancreatic B-cells
  1085. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances
  1086. Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases
  1087. Role of CYP2E1 in the Epoxidation of Acrylamide to Glycidamide and Formation of DNA and Hemoglobin Adducts
  1088. Role of CYP2E1 in the hepatotoxicity of acetaminophen
  1089. Role of CYP2E1 in the mouse model of MPTP toxicity
  1090. Role of CYP2E1 in the pathogenesis of alcoholic liver disease
  1091. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway
  1092. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity
  1093. Role of CYP2E1 polymorphisms in breast cancer: a systematic review and meta-analysis
  1094. Role of CYP2E1-mediated metabolism in the acute and vestibular toxicities of nineteen nitriles in the mouse
  1095. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and CYP2E1 (–/–) mice
  1096. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1
  1097. Role of exposure/recovery schedule in micronuclei induction by several promutagens in V79-derived cells expressing human CYP2E1 and SULT1A1
  1098. Role of intracellular calcium and phospholipase A2 in arachidonic acid-induced toxicity in liver cells overexpressing CYP2E1
  1099. Role of mouse CYP2E1 in the O-hydroxylation of p-nitrophenol: comparison of activities in hepatic microsomes from CYP2E1 (-/-) and wild-type mice
  1100. Role of nitric oxide and nuclear factor-κB in the CYP2E1 potentiation of tumor necrosis factor α hepatotoxicity in mice
  1101. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia
  1102. Role of P38 MAP kinase in CYP2E1 dependent arachidonic acid toxicity
  1103. Role of p38 MAPK in CYP2E1-dependent arachidonic acid toxicity
  1104. Role of phosphatidylinositol 3-kinase/AKT as a survival pathway against CYP2E1-dependent toxicity
  1105. Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells
  1106. CYP2E1_and_cyp2d6_genes_in.5.aspx”>Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes
  1107. Role of polymorphic variants of cytochrome P450 genes (CYP1A1, CYP2E1) and microsomal epoxide hydrolase (mEPHX) in pathogenesis of cystic fibrosis and …
  1108. Role of the Genetic Polymorphisms in the 5′‐Flanking Region for Transcriptional Regulation of the Human CYP2E1 Gene
  1109. Role of the Liver-Enriched Transcription Factor HNF-1α in Expression of the CYP2E1 Gene
  1110. Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells
  1111. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis
  1112. Roles of CYP2E1 in 1, 2‐dichloroethane‐induced liver damage in mice
  1113. Roles of CYP2E1 in liver damage induced by 1, 2-dichloroethane
  1114. Romidepsin (FK228) in a Mouse Model of Lipopolysaccharide-Induced Acute Kidney Injury is Associated with Down-Regulation of the CYP2E1 Gene
  1115. RORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure
  1116. RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case–control study
  1117. Ruthenium red protects HepG2 cells overexpressing CYP2E1 against acetaminophen cytotoxicity
  1118. S29. 1 CORRELATION BETWEEN SPERMATOGENESIS DISORDERS AND CYP2E1 MRNA EXPRESSION IN RATS TESTES FOLLOWING CHRONIC …
  1119. S-adenosyl methionine protects ob/ob mice from CYP2E1-mediated liver injury
  1120. S-adenosyl-L-methionine attenuates hepatotoxicity induced by agonistic Jo2 Fas antibody following CYP2E1 induction in mice
  1121. Safrole-DNA adducts in human peripheral blood—an association with areca quid chewing and CYP2E1 polymorphisms
  1122. Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation
  1123. Salvia fruticosa Modulates mRNA Expressions and Activity Levels of Xenobiotic Metabolizing CYP1A2, CYP2E1, NQO1, GPx, and GST Enzymes in Human …
  1124. Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat
  1125. Selective time-and NADPH-dependent inhibition of human CYP2E1 by clomethiazole
  1126. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of liver graft hepatitis C recurrence
  1127. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C
  1128. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1
  1129. Sex steroid hormones regulate constitutive expression of CYP2E1 in female mouse liver
  1130. Shanxi aged vinegar prevents alcoholic liver injury by inhibiting CYP2E1 and NADPH oxidase activities
  1131. Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in CYP2E1 (-/-) mice
  1132. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia
  1133. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations
  1134. Silver Nanoparticle-Doped Poly (8-Anilino-1-Naphthalene Sulphonic Acid)/CYP2E1 Nanobiosensor for Isoniazid-A First Line Anti-Tuberculosis Drug
  1135. Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?
  1136. Similarity Check: Genotype Polymorphisms Of Nat2 And CYP2E1 Genes Associated With Drug Induced Liver Injury (Dili) In Indonesian Tuberculosis Patients
  1137. Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses
  1138. Single-nucleotide polymorphisms in cytochrome P450 2E1 (CYP2E1) 3′-untranslated region affect the regulation of CYP2E1 by miR-570
  1139. Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes
  1140. Spectrophotometric Analysis of Human CYP2E1-Catalyzed p-Nitrophenol Hydroxylation
  1141. Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity
  1142. St. John’s wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse
  1143. Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N, N-dimethylnitrosamine in cytotoxicity testing
  1144. Striking LD50 variation associated with fluctuations of CYP2E1-positive cells in hepatic lobule during chronic CCl4 exposure in mice
  1145. Structure of pyrazole derivatives impact their affinity, stoichiometry, and cooperative interactions for CYP2E1 complexes
  1146. Structure-functional characterization of cytochrome P4502E1 (CYP2E1)
  1147. Structure-toxicity relationship study of para-halogenated styrene analogues in CYP2E1 transgenic cells
  1148. CYP2E1.7.aspx”>Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe
  1149. Studies on Pharmacokinetic Interaction Among CYP1A2, CYP2E1 and CYP3A4 Probes in Rats [J]
  1150. Study of CYP2E1 gene RsaI/PstI polymorphisms in patients with gastric cancer in north of Iran
  1151. Study of genetic polymorphisms of CYP2E1 and GSTM1
  1152. Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis
  1153. Study of the fragmentation mechanism of protonated 6-hydroxychlorzoxazone: application in simultaneous analysis of CYP2E1 activity with major human cytochrome …
  1154. STUDY ON AA METABOLISM IN RAT LIVER AND THE EXPRESSION OF CYP2E1
  1155. Study on Chinese medicine constitution and its relation with CYP2E1 gene polymorphisms of anti‐tuberculosis drug‐induced hepatitis
  1156. Study on inhibitory effect of water extract of Polygonum multiflorum on CYP1A2 and CYP2E1 enzymatic activities and mRNA expressions in rat liver
  1157. Study on the association between CYP2E1 enzymes and susceptibility of alcoholic liver disease
  1158. Study on the association between genetic polymorphism of CYP2E1, GSTM1 and susceptibility of lung cancer
  1159. Study the effect of Baijie Capsule on cytochrome P450 isozymes CYP2C19, CYP2E1 by cocktail probe drugs
  1160. Study the effect of cytochrome p450 isozymes cyp1A2, cyp3A4, CYP2E1 following administration of Zhenqi Fuzheng Capsules by cocktail probe drugs [J]
  1161. Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates
  1162. Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis
  1163. Suppression of cytochrome P450 2E1 promoter activity by interferon-γ and loss of response due to the-71G> T nucleotide polymorphism of the CYP2E1* 7B allele
  1164. Sus scrofa mRNA for cytochrome p450 2E1 (CYP2E1 gene)
  1165. Sus scrofa partial CYP2E1 gene for cytochrome p450 2E1, exon 9 and partial CDS
  1166. Susceptibility to the acute toxicity of acrylonitrile in streptozotocin-induced diabetic rats: protective effect of phenethyl isothiocyanate, a phytochemical CYP2E1 …
  1167. Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese
  1168. Synergistic toxic interactions between CYP2E1, LPS/TNFα, and JNK/p38 MAP kinase and their implications in alcohol-induced liver injury
  1169. Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1
  1170. Synonymous mutation rs2515641 affects CYP2E1 mRNA and protein expression and susceptibility to drug-induced liver injury
  1171. Tandem Repeat Polymorphism of the CYP2E1 Gene: An Association Study With Esophageal Cancer and Lung Cancer
  1172. Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices
  1173. Targeted delivery of CYP2E1 recombinant adenovirus to malignant melanoma by bone marrow-derived mesenchymal stem cells as vehicles
  1174. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation
  1175. Tetra primer ARMS PCR optimization to detect single nucleotide polymorphisms of the CYP2E1 gene
  1176. The Action of Cytochrome b5 on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
  1177. The activity, protein, and mRNA expression of CYP2E1 and CYP3A1 in rats after exposure to acute and chronic high altitude hypoxia
  1178. The ADH3* 2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men
  1179. The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression
  1180. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis
  1181. The Association of CYP2E1 Polymorphism and Environmental Factor in Nasopharyngeal Carcinoma Patients
  1182. The Changes in the Analgesic Effect of Probe Drug Chlorzoxazone Metabolized by CYP2E1 on Alcoholic Liver Injury in Rats
  1183. The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2-and Akt-dependent mechanism
  1184. The CYP2E1-humanized transgenic mouse: role of CYP2E1 in acetaminophen hepatotoxicity
  1185. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine
  1186. The difference of metabolism activity of CYP2E1 between in immune liver damage rats and in alcohol-mediated hepatic injury rats
  1187. The effect of changes in CYP2E1 activity in the liver on toxicity and carcinogenicity of diethylnitrosamine in mice
  1188. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells
  1189. The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat
  1190. The effect of ethanol and nitric oxide on the N-nitrosodimethylamine formation in HepG2 cells overexpressing CYP2E1
  1191. THE EFFECT OF ETHANOL ON COUMARIN METABOLISM AND CYTOTOXICITY IN TRANSFECTED CULTURES OF HEPG2 CELLS WITH CYP2E1 EXPRESSION.
  1192. The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal
  1193. The Effect of Huangqi on CYP2E1 Activity of Diabetic Rats
  1194. The effect of isoniazid containing regimen on CYP2E1 during antituberculosis therapy.
  1195. The effect of isoniazid on CYP2E1-and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney
  1196. The effect of lycopene on the total cytochrome P450, CYP1A2 and CYP2E1
  1197. The effect of organic solvents and CYP1A1, CYP2E1, GSTM1 polymorphisms on the development of acute lymphoblastic leukemia in Quebec children
  1198. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects
  1199. The effect of SNPs in the promoter on expression of CYP2E1 gene and boar taint
  1200. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone
  1201. The effects of bovine serum albumin on kinetic characterization of human liver microsomal CYP2C19 and CYP2E1 activities
  1202. The Effects of CYP2E1 on Hepatic Gene Expression in 129/Sv-CYP2E1^ tm1Gonz/J and 129S1/SvImJ Mice Exposed to Hydrazine
  1203. The effects of non-esterified fatty acids and β-hydroxybutyrate on the hepatic CYP2E1 in cows with clinical ketosis
  1204. The Effects of Poly IC and Human Interferon ɑ on Rat Hepatic Cyp4a1 and CYP2E1.
  1205. The effects of the ALDH2* 1/2, CYP2E1 c1/c2 and C/D genotypes on blood ethanol elimination and the human serotonin receptor (HTR2) gene Msp1 polymorphism in …
  1206. THE EFFECTS OF THE ALDH2*1/2, CYP2E1 C1/C2 AND C/D GENOTYPES ON BLOOD ETHANOL ELIMINATION
  1207. The effects of toluene on the total CYP450 content and on levels of CYP2E1 and 2B6 Isoforms in the rat liver
  1208. The essential role of CYP2E1 in metabolism and hepatotoxicity of N,N-dimethylformamide using a novel CYP2E1 knockout mouse model and a population study
  1209. The ethanol elimination pharmacokinetics–the effects of genotypes of ALDH2 and CYP2E1 on the ethanol metabolism
  1210. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage
  1211. The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
  1212. The genetic regulation of liver microsomal CYP2E1 activity among strains of the viviparous fish Poeciliopsis
  1213. The genotype of CYP2E1 and liver-derived serum enzymes
  1214. The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function
  1215. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finish study population
  1216. The impact of CYP1A2 and CYP2E1 genes polymorphism on theophylline response
  1217. The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures
  1218. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model
  1219. The impact of psychogenic stressors on oxidative stress markers and patterns of CYP2E1 expression in mice liver
  1220. The importance of CYP2E1 in the pathogenesis of alcoholic liver disease and drug toxicity and the role of the proteasome
  1221. The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation
  1222. The induction of the human hepatic CYP2E1 gene by interleukin 4 is transcriptional and regulated by protein kinase C
  1223. The influence of genetic polymorphism of CYP2E1 on the development of alcohol liver cirrhosis
  1224. The influence of Jiuganning decoction on the content of CYP2E1 and cytokine IL-6, TNF in rats models of alcoholic hepatic injury
  1225. The Inhibitory Effect of the Derris scandens Extract on Cytochrome P450 2E1 (CYP2E1)-associated Aniline-4-Hydroxylase in vitro
  1226. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway
  1227. The Meta Isomer of Acetaminophen Is A Time Dependent Inhibitor of Human CYP2E1
  1228. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin
  1229. The modeling of interactions of the CYP2E1 isoform of human cytochrome P450 with substrates
  1230. The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide
  1231. The molecular mechanism regulating 24‐hour rhythm of CYP2E1 expression in the mouse liver
  1232. The NH2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase
  1233. The Physiological Mechanism of Improved Formaldehyde Resistance in Petunia hybrida Harboring a Mammalian CYP2E1 Gene
  1234. The Physiological Mechanism of Petunia hybrida Harboring Mammalian CYP2E1 Gene Improving Resistance to Formaldehyde
  1235. The pig CYP2E1 promoter is activated by COUP-TF1 and HNF-1 and is inhibited by androstenone
  1236. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies
  1237. The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans
  1238. The possible mechanisms of CYP2E1 interactions with HSP90 and the influence of ethanol on them
  1239. The regulation of CYP2E1 gene expression and its role in breast cancer
  1240. CYP2E1-genotype-and-ab”>The relationship between the GST T1, GST M1, CYP2E1 genotype and abnormal liver function in PVC workers
  1241. The research on the relationship between CD44, CYP2E1 genetic polymorphisms and esophageal cancer
  1242. The role of CYP2A and CYP2E1 in the metabolism of 3-methylindole in primary cultured porcine hepatocytes
  1243. The role of CYP2A6 and CYP2E1 in the metabolism of 3-methylindole in porcine hepatocytes.
  1244. The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives
  1245. The role of CYP2E1 and CYP4A in the development of non-alcoholic steatohepatitis
  1246. The Role of CYP2E1 IgG4 Subclass Autoantibodies in the Development of Anesthetic Sensitization
  1247. The role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system
  1248. The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain
  1249. The role of CYP2E1 in the protection of garlic oil’s from n-hexane-induced neurotoxicity
  1250. THE ROLE OF CYP2E1 POLYMORPHISM IN THE ACTIVATION OF PROCARCINOGEN METABOLISM OF NASOPHARYNGEAL CARCINOMA
  1251. The role of inflammatory and oxidative stress, CYP2E1 and bile acid disturbance in rat liver injury induced by isoniazid and lipopolysaccharide co-treatment
  1252. The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression
  1253. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol …
  1254. The WNT/β-catenin pathway is a transcriptional regulator of CYP2E1, CYP1A2, and aryl hydrocarbon receptor gene expression in primary human hepatocytes
  1255. Theoretical study of the mechanism of acetaldehyde hydroxylation by compound I of CYP2E1
  1256. Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model
  1257. Therapeutic potential of CYP2E1 inhibitor combined N-acetyl-cysteine in acute acrylonitrile intoxication in rats
  1258. Tightly regulated and inducible expression of rabbit CYP2E1 using a tetracycline-controlled expression system
  1259. Tissue-specific expression and methylation of the human CYP2E1 gene
  1260. Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2
  1261. Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes
  1262. Transcription factor Nrf2 protects HepG2 cells against CYP2E1 plus arachidonic acid-dependent toxicity
  1263. Transcriptional activity of the tandem repeat polymorphism in the 5′‐flanking region of the human CYP2E1 gene
  1264. CYP2E1&ots=AGYoKkGapZ&sig=lKqFX7Bx9cBbiySnxK-Kg_pu_Gk”>Transcriptional and posttranscriptional regulation of CYP2E1, an N-nitrosodimethylamine demethylase
  1265. Transcriptional control of CYP2E1 in the perivenous liver region and during starvation
  1266. Transcriptional control of the rat hepatic CYP2E1 gene.
  1267. Transfected HepG2 cells for evaluation of catechin effects on alcohol-induced CYP2E1 cytotoxicity
  1268. Transgenic alfalfa plants co-expressing glutathione S-transferase (GST) and human CYP2E1 show enhanced resistance to mixed contaminates of heavy metals and …
  1269. Transgenic plant regeneration of tobacco (Nicotiana tabacum) haboring mammalian CYP2E1 gene
  1270. Transgenic plants of Petunia hybrida harboring the CYP2E1 gene efficiently remove benzene and toluene pollutants and improve resistance to formaldehyde
  1271. Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid
  1272. Trifluoroacetylated adducts in spermatozoa, testes, liver and plasma and CYP2E1 induction in rats after subchronic inhalatory exposure to halothane
  1273. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1
  1274. Trimethadione N-demethylation by rat liver CYP2E1 in vitro.
  1275. TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity
  1276. TRPV4 attenuates M1 polarization and subsequent NASH progression by stalling CYP2E1-mediated redox toxicity via eNOS.
  1277. TRPV4 Modulates CYP2E1 Function in Nonalcoholic Steatohepatitis Progression
  1278. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid …
  1279. Undernutrition during hyperoxic exposure induces CYP2E1 in rat liver
  1280. Unraveling CYP2E1 haplotypes in alcoholics from Central Brazil: A comparative study with 1000 genomes population
  1281. UPREGULATING OF CYP2E1 IN ETHANOL-FED MICE WITH TRANSGENIC OVEREXPRESSION OF CTRP3
  1282. Upregulation of CYP2E1 and cyp3a activities in histamine-deficient histidine decarboxylase gene targeted mice
  1283. Upregulation of CYP2E1 expression causes oxidative damage induced by 2-chloroethanol in primary cultured rat astrocytes
  1284. Urinary Biomarker of Prenatal Exposure to Disinfection Byproducts, Maternal Genetic Polymorphisms in CYP2E1 and GSTZ1, and Birth Outcomes
  1285. Urinary excretion of 6‐hydroxychlorzoxazone as an index of CYP2E1 activity
  1286. Use of CYP2E1‐transfected human liver cell lines in elucidating the actions of ethanol
  1287. Use of Cytochrome P450 2E1 (CYP2E1) Knockout Transgenic Mouse Model to Study the Role of CYP2E1 in Carbon Tetrachloride-and Alcohol-mediated …
  1288. Use of molecular simulation for mapping conformational CYP2E1 epitopes
  1289. Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene
  1290. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques
  1291. Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1
  1292. Value of polymorphisms and DNA methylation for the expression of CYP2E1 enzyme: implications in pharmacogenomics
  1293. Variable Number of Tandem Repeats (VNTR) gene polymorphism of CYP2E1 in patients with pancreatic adenocarcinoma
  1294. Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome?
  1295. Variations in expression of CYP2E1 and COUP-TF1 proteins between Large White and Duroc cross-breeds
  1296. Voglibose potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen by inducing CYP2E1 in rats
  1297. Watercress has no importance for the elimination of ethanol by CYP2E1 inhibition
  1298. XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed …
  1299. XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl …
  1300. Zebrafish have an ethanol-inducible hepatic 4-nitrophenol hydroxylase that is not CYP2E1-like
  1301. ZSCAN25 and CYP2E1 polymorphisms is risk factors for ischemic stroke in a Chinese Han population: a case control study
  1302. π–π Stacking mediated drug–drug interactions in human CYP2E1

Related Posts

Shopping Cart
Scroll to Top